sundance10-q_12312015.htm

SUNDANCE STRATEGIES, INC.

February 9, 2016

/s/ Randall F. Pearson

Randall F. Pearson

President, Chief Executive Officer and Acting Chief Financial Officer

0000912282-16-000555.txt : 20160209 0000912282-16-000555.hdr.sgml : 20160209 20160209142853 ACCESSION NUMBER: 0000912282-16-000555 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160209 DATE AS OF CHANGE: 20160209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sundance Strategies, Inc. CENTRAL INDEX KEY: 0001171838 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 880515333 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50547 FILM NUMBER: 161398814 BUSINESS ADDRESS: STREET 1: 4626 NORTH 300 WEST, SUITE 365 CITY: PROVO STATE: UT ZIP: 84604 BUSINESS PHONE: 801-705-8968 MAIL ADDRESS: STREET 1: 4626 NORTH 300 WEST, SUITE 365 CITY: PROVO STATE: UT ZIP: 84604 FORMER COMPANY: FORMER CONFORMED NAME: JAVA EXPRESS INC DATE OF NAME CHANGE: 20020422 10-Q 1 sundance10-q_12312015.htm sundance10-q_12312015.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended December 31, 2015

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to _________

Commission File Number 000-50547

SUNDANCE STRATEGIES, INC.

(Exact name of registrant as specified in its charter)

Nevada		88-0515333
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

4626 North 300 West, Suite No. 36, Provo, Utah		84604
(Address of principal executive offices)		(Zip Code)

(801) 705-8968

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o	Accelerated filer x
Non-accelerated filer o	Smaller reporting company o
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes o No x

As of February [5], 2016 the registrant had [44,315,941] shares of common stock, par value $0.001, issued and outstanding.

SUNDANCE STRATEGIES, INC.

FORM 10-Q

TABLE OF CONTENTS

		Page

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements		3
	Condensed Consolidated Balance Sheets as of December 31, 2015 (Unaudited) and March 31, 2015	4
	Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) for the three and nine month periods ended December 31, 2015 and 2014	5
	Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine month periods ended December 31, 2015 and 2014	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	7 - 13

Item 2. Management’s Discussion and Analysis of Financial Condition And Results of Operations		14

Item 3. Quantitative and Qualitative Disclosure about Market Risk		19

Item 4. Controls and Procedures		19

PART II — OTHER INFORMATION		19

Item 1. Legal Proceedings		19

Item 1A. Risk Factors		20

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		20

Item 3. Defaults upon Senior Securities		20

Item 4. Mine Safety Disclosures		20

Item 5. Other Information		20

Item 6. Exhibits		20

Signatures		21

Item 1. Financial Statements

The Condensed Consolidated Financial Statements of the Company required to be filed with this Quarterly Report were prepared by management and commence below, together with related notes. In the opinion of management, the Condensed Consolidated Financial Statements fairly present the financial condition of the Company and include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s Condensed Consolidated Financial Statements. The results from operations for the three and nine month period ended December 31, 2015, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2016. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the March 31, 2015, Consolidated Financial Statements and footnotes thereto included in the Company’s 10-K Annual Report for the fiscal year ended March 31, 2015, which was filed with the SEC on June 15, 2015, and which is referenced in Part II, Item 6, below.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Balance Sheets

December 31, 2015 and March 31, 2015

(Unaudited)

	December 31,				March 31,
	2015				2015
ASSETS

Current Assets
Cash and Cash Equivalents		$	74,114			$	336,370
Prepaid Expenses			3,750				1,875

Total Current Assets			77,864				338,245

Other Assets
Investment in Net Insurance Benefits			28,690,516				22,544,635
Advance for Investment in Net Insurance Benefits			-				3,596,386
Notes Receivable			-				211,000
Other			-				16,428
			-				-
Total Other Long-term Assets			28,690,516				26,368,449

Total Assets		$	28,768,380			$	26,706,694

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
Accounts Payable		$	279,128			$	255,361
Accrued Expenses			826,665				181,917
Notes Payable			-				1,326,876
Note Payable-Related Party			-				1,500,000
Redeemed Common Stock Payable			750,000				-

Total Current Liabilities			1,855,793				3,264,154

Long-Term Liabilities
Note Payable-Related Party			2,667,000				-
Convertible Debenture			700,000				-
Accrued Expenses			109,800				-

Total Long-Term Liabilities			3,476,800				-

Total Liabilities			5,332,593				3,264,154

Stockholders' Equity
Preferred Stock, authorized 10,000,000 shares,
par value $0.001; -0- shares issued and outstanding			-				-
Common Stock, authorized 500,000,000 shares,
par value $0.001; 44,222,191 and 43,185,941 shares issued and outstanding, respectively			44,222				43,186
Additional Paid In Capital			24,260,505				16,316,882
Additional Paid In Capital- Stock to be Issued			-				7,540,000
Accumulated Deficit			(868,940	)			(457,528	)

Total Stockholders' Equity			23,435,787				23,442,540

Total Liabilities and Stockholders' Equity		$	28,768,380			$	26,706,694

The accompanying notes are an integral part of these condensed consolidated financial statements.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Operations

For the Three and Nine Months Ended December 31, 2015 and 2014

(Unaudited)

	Three Months Ended			Three Months Ended			Nine Months Ended			Nine Months Ended
	December 31,			December 31,			December 31,			December 31,
	2015			2014			2015			2014

Interest Income on Investment in Net Insurance Benefits	$	1,090,031		$	616,547		$	2,777,501		$	1,772,698

General and Administrative Expenses		1,549,676			526,797			3,043,267			1,726,169

Income (Loss) from Operations		(459,645	)		89,750			(265,766	)		46,529

Other Income (Expense)
Interest Income		-			4,568			5,241			13,388
Interest Expense		(60,294	)		(200,270	)		(150,887	)		(233,442	)
Other, net		-			-			-			6,303

Total Other Expense		(60,294	)		(195,702	)		(145,646	)		(213,751	)

Loss Before Income Taxes		(519,939	)		(105,952	)		(411,412	)		(167,222	)
Income Tax Provision		-			-			-			-

Net Loss	$	(519,939	)	$	(105,952	)	$	(411,412	)	$	(167,222	)

Basic and Diluted:
Loss Per Share	$	(0.01	)	$	(0.01	)	$	(0.01	)	$	(0.01	)

Basic Weighted Average Number of Shares Outstanding		44,315,941			43,185,941			44,029,347			43,122,354

The accompanying notes are an integral part of these condensed consolidated financial statements.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Cash Flows

Nine Months Ended December 31, 2015 and 2014

(Unaudited)

	Nine Months Ended			Nine Months Ended
	December 31,			December 31,
	2015			2014

Operating Activities

Net Loss	$	(411,412	)	$	(167,222	)
Adjustments to reconcile to cash from operating activities:
Share Based Compensation - Options		404,659			320,333
Accrued Interest on NIBs		(2,777,501	)		(1,772,698	)
Advance for Investments in Net Insurance Benefits		(626,914	)		(794,598	)
Refund of Advance for Investments in Net Insurance Benefits		854,920			904,274
Changes in Operating Assets and Liabilities
Accrued Interest Income		16,428			(4,847	)
Prepaid Expenses		(1,875	)		(1,750	)
Accounts Payable		23,767			75,339
Accrued Expenses		927,672			34,430

Net Cash from Operating Activities		(1,590,256	)		(1,406,739	)

Investing Activity

Issuance of Note Receivable		-			(150,000	)
Proceeds from Notes Receivable		211,000			550,000

Net Cash from Investing Activity		211,000			400,000

Financing Activities

Proceeds from Issuance of Notes Payable and Lines-of-Credit, Related Party		1,167,000			1,272,000
Proceeds from Issuance of Convertible Debenture		700,000			-
Common Stock Issued for Cash		-			150,000
Redemption of Temporary Equity		(750,000	)		-

Net Cash from Financing Activities		1,117,000			1,422,000

Net Change in Cash		(262,256	)		415,261
Cash at Beginning of Period		336,370			375,212

Cash at End of Period	$	74,114		$	790,473

Non Cash Financing & Investing Activities
Notes Receivables Exchanged for Advance for Investment in NIBs	$	-		$	100,000
Cash Paid for Interest	$	-		$	81,621
Adjustments to Subscription Receivable and Additional Paid In Capital	$	-		$	1,500
Exchange Note Payable and Accrued Interest for Temporary Equity	$	1,500,000		$	-
Advanced funds paid converted to Net Insurance Benefits	$	3,368,380		$	-

The accompanying notes are an integral part of these condensed consolidated financial statements.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(1) ORGANIZATION AND BASIS OF PRESENTATION

The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company’s annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the March 31, 2015, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated condensed financial statements and accompanying notes. Actual results could differ materially from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.

Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies,” the “Company” or “we”). The Company is engaged in the business of purchasing or acquiring and selling life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” Currently, the Company is focused on the purchase and sale of net insurance benefit contracts (“NIB”) on life insurance policies between the sellers and purchasers, but does not take possession or control of the policies. The purchasers acquire the life insurance policies at a discount to their face value for investment purposes. The purchasers have available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the NIB after all borrowings, interest and expenses have been paid out of the settlement proceeds.

(2) NEW ACCOUNTING PRONOUNCEMENTS

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The Company is currently evaluating the guidance, including which transition approach will be applied and the estimated impact it will have on our consolidated financial statements. The Company does not believe adoption of this ASU will have a material impact on its financial statements.

In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(2) NEW ACCOUNTING PRONOUNCEMENTS (Continued)

The new standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years,

beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

In April, 2015, the FASB issued ASU 2016-01: Simplifying the Presentation of Debt Issuance Costs (Subtopic 835-30). This update requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. Under current standards, debt issuance costs are generally recorded as an asset and amortization of these deferred financing costs is recorded in interest expense. Under the new standard, debt issuance costs will continue to be amortized over the life of the debt instrument and amortization will continue to be recorded in interest expense. ASU 2015-03 is effective for the Company on April 1, 2016, and will be applied on a retrospective basis.

In May 2015, the FASB issued ASU 2015-08, Business Combinations (Topic 805): Pushdown Accounting. This Accounting Standards Update amends various SEC paragraphs pursuant to the issuance of Staff Accounting Bulletin No.115. The Company notes the Update is effective immediately and will apply to the Company if the Company acquires a business.

In August 2015, the FASB issued ASU 2015-15, Interest-Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. This Update was issued to make some fairly minor wording adjustments to ASC 835-30. The new wording, presented as paragraph 835-30-S45-1, recognizes that ASU 2015-13 does not address the presentation and subsequent measurement of debt issuance costs related to line-of-credit arrangements. As stated below, ASU 2015-13 requires companies to recognize debt issuance costs as a reduction of the carrying amount of the associated debt liability. ASU 2015-15 states that debt issuance costs related to line-of-credit arrangements may be recognized as an asset and amortized over the term of the line-of-credit arrangement, even if the line-of-credit does not carry a balance. The Company notes that this guidance does apply to its reporting requirements and will implement the new guidance accordingly.

In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. This Update, which is part of the FASB’s larger Simplification Initiative project aimed at reducing the cost and complexity of certain areas of the accounting codification, requires that an acquirer recognize adjustments to provisional amounts identified during the measurement period in the reporting period in which the adjustment amounts are determined. Furthermore, the acquirer should record in the same period’s financial statements, the effect on earnings from any changes in depreciation, amortization or other items impacting income. These changes resulting from adjustments to provisional amounts should be calculated as if the accounting had been completed at the actual acquisition date. Lastly, the Update requires the acquirer to present separately on the face of the income statement or in the footnote disclosures the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the actual acquisition date. This Update is effective for fiscal years beginning after December 15, 2016. The amendments in this Update should be applied prospectively to adjustments to provisional amounts that occur after the effective date of this Update, with earlier application permitted. The amendments are effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. All entities have the option of adopting the new requirements as of an earlier date for financial statements that have not been previously issued. Applicable disclosures for a change in an accounting principle are required in the year of adoption, including interim periods. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. The Company notes that this guidance may apply to its reporting requirements and will implement the new guidance accordingly.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(2) NEW ACCOUNTING PRONOUNCEMENTS (Continued)

In November 2015, the FASB issued ASU 2015-17 regarding Balance Sheet Classification of Deferred Taxes, which simplifies the presentation of deferred income taxes by requiring all deferred income tax liabilities and assets be classified as noncurrent on the consolidated balance sheets. The guidance is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2016, with early adoption permitted. The standard would be effective for the Company’s fiscal year beginning April 1, 2017, however, we expect to early adopt the provisions of this standard effective January 1, 2016 on a prospective basis. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements.

In January 2016, the FASB issued ASU 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company’s fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements.

The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

(3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS

On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”).

The Del Mar ATA involved the purchase of certain life settlement assets consisting of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. According to the Del Mar ATA, Del Mar, with the assistance of Europa, was obligated to convert the NIBs and other newly acquired NIBs into “Qualified NIBS.” As soon as Del Mar met its obligation to provide Qualified NIBs to the Company, any remaining NIBs and any other consideration and collateral would be returned or released to Del Mar. The original due date for the conversion was December 31, 2013, which date was subsequently extended several times. On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related Europa Agreement to extend the deadline until August 31, 2015.

The remaining consideration and collateral under the Del Mar ATA, as of September 1, 2015, primarily consisted of approximately 81% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. During June 2015, one of the life settlement policies matured for $10,000,000 (the “Matured Policy”), lowering the remaining face value of such life settlement policies to $84,000,000. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a senior lender.

As Del Mar was unable to provide the required amount of Qualified NIBs by the extended due date of August 31, 2015, effective September 1, 2015, the agreements with Del Mar and Europa were cancelled

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Continued)

and the Company obtained full ownership and control of the collateral, which included the above mentioned approximately 81% of the NIBs associated with the $84,000,000 face value of life settlement policies and certain rights to net proceeds relating to the Matured Policy.

The bulk of the $10,000,000 proceeds paid in connection with the Matured Policy were used to repay loans secured by such Matured Policy. However, on September 10, 2015, the Company received $1,094,335 as a result of the rights associated with the Matured Policy. These proceeds were allocated $239,415 to pay off a note receivable (including interest), $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar and $307,612 as a refund of advance payments previously made to or on behalf of

Del Mar as part of the Del Mar ATA. The $547,308 and $307,612 proceeds, which together total $854,920, were applied to reduce Advance for Investment in NIBs.

On September 30, 2015, the Company transferred the remaining balance of advances and expense payments to Del Mar, totaling $3,368,380, which approximates fair value. This amount was residing in advance for investment in NIBs before being transferred to investment in NIBs (see Note 4).

In addition to obtaining full and unrestricted rights to the NIBs upon termination of the Del Mar ATA and Europa Agreement, the Company also is entitled to receive liquidated damages from Del Mar in an amount equal to 100% of any cash advances made under the Del Mar ATA. The Company is currently determining the extent of the liquidated damages claim and Del Mar’s ability to pay any such liquidated damages. The liquidated damages are computed pro rata, based upon the percentage of Qualified NIBs delivered by Del Mar under the Del Mar ATA. The Company received $90,600,000 in Qualified NIBs or approximately 22.65% of the $400,000,000 in Qualified NIBs due under the Del Mar ATA. Accordingly, once 22.65% of its costs and expenses are deducted, the Company would be entitled to receive the remaining amount of its costs and expenses, times two, as liquidated damages. As a result of the termination, the Company has no further payment obligations to Del Mar or fee obligations to Europa. The Company is determining whether Europa is liable to the Company for any damages related to Del Mar’s failure to provide the required Qualified NIBs.

The liquidated damages claim is secured by all of the assets transferred to the Company under the Del Mar ATA and a Collateral Pledge Agreement executed by Del Mar on June 5, 2013, pledging all of Del Mar’s remaining assets to the Company unless and until Del Mar completes all of its obligations under the Del Mar ATA. The Company is unsure what, if any, assets are currently held by Del Mar.

(4) INVESTMENT IN NET INSURANCE BENEFITS

Investment in NIBs for the nine months ended December 31, 2015, and the fiscal year ended March 31, 2015, were as follows:

	December 31, 2015		March 31, 2015
Beginning Balance	$	22,544,635	$	12,243,411
Additional investments		3,368,380		7,846,746
Accretion of interest income		2,777,501		2,454,478
Distributions of investments		-		-
Impairment of investments		-		-
Total	$	28,690,516	$	22,544,635

As mentioned in Note 3, the Company transferred $3,368,380 from advance for investment in NIBs into investment in NIBs on September 30, 2015.

The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(4) INVESTMENT IN NET INSURANCE BENEFITS (continued)

mortality risk insurance product or mortality re-insurance (“MRI”). Future expected cash flow is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment and service provider or other third-party payments. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2015. The Company holds between 81% and 100% in the NIBs relating to the underlying life insurance policies as of December 31, 2015.

The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations. Subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income. We have not recognized any significant adverse change in future estimated cash flows relating to our investment in NIBs from January 31, 2013 (inception) to the period ended December 31, 2015.

During July, 2015, a group of persons located in the United States (the “Purchasers”) acquired the entities that owned all of the portfolios of life insurance contracts underlying the Company’s NIBs. The Purchasers have also agreed to amend the NIBs agreements to provide greater disclosure to the Company and limit permitted expenses to be paid prior to payments to the NIBs holders, pending certain regulatory and tax approvals. In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a Settlement Agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts. The Purchasers further required releases from the Company and the payment of certain accrued expenses. Accordingly, effective as of July 17, 2015, the Purchasers acquired all of the ownership interests in the entities that owned all of the portfolios of life insurance contracts underlying the Company’s NIBs from their prior owners and executed a Settlement Agreement with such owners and the Company in relation to these matters. The NIBs amendments are in process, and the Company believes the NIBs amendments will be in effect within the next three months. The Company and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership or management of the entities sold, based on actions that occurred prior to this sale to the Purchasers. During the three months ended December 31, 2015, the Company accrued for an $826,665 obligation related to the ownership change, which is recorded in General and Administrative Expenses. Management of the Company is presently not aware of the existence of any additional payments owed. Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in our NIBs ownership interest. The Company was supportive of the Purchasers acquiring the entities that owned the portfolios of life insurance contracts underlying the Company’s NIBs and was willing to provide the indemnification because it believes this ownership change will result in a reduction of costs and expenses associated with ownership of the NIBs, which should increase their intrinsic value.

(5) NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY

As of December 31, 2015, the Company had borrowed $2,667,000 from related parties under notes payable and lines-of-credit Agreements that allow for borrowings of up to $3,245,000 through the earlier of June 30, 2017, or when the Company completes a successful equity raise, at which time principal and interest is due in full. The notes payable and lines-of-credit incur interest at 7.5 percent, allow for origination fees

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(5) NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (continued)

and are collateralized by Advance for Investment in NIBs. The Company borrowed $1,367,000 under these agreements during the nine months ended December 31, 2015. The Company also repaid $200,000 during the nine months ended December 31, 2015. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. See Note 10 for amendment of this agreement subsequent to period end.

(6) NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE

At March 31, 2014, the Company owed $1,455,904, including accrued interest for notes payable. During the year ended March 31, 2015, the Company had accrued an additional $37,350 in interest. The note incurred interest at 4%, was collateralized by NIBs and was due April 2015. During the three months ended June 30, 2015, the note payable and related accrued interest was converted to temporary equity through the issuance of 187,500 shares of common stock with a redemption feature (See Part II, Item 5, below). On June 9, 2015, the holder of the redemption feature exercised a portion of the redemption right relating to 93,750 shares and, as a result, the holder accepted the Company’s redemption payment of $750,000. The redemption feature on the remaining 93,750 shares was eligible to be exercised by the holders on October 31, 2015. The holders of the redemption feature exercised the redemption feature on October 31, 2015, thus requiring the Company to pay the redemption feature, and the Company originally had elected to exercise its 45 day Cure Period to make the redemption payment of $750,000 on or before December 15, 2015, in consideration of the cancellation of the 93,750 common shares. As a result of the redemption feature being exercised by the holder, the $750,000 associated with the redemption has been reclassified from Temporary Equity to Redeemed Common Stock Payable. To date the cure period with the holder of the redemption feature has expired. The Company and the redemption holder are negotiating the terms and conditions of an extension agreement and anticipate completion by February 15, 2016.

(7) CONVERTIBLE DEBENTURE AGREEMENT

On June 2, 2015, the Company entered into an 8% Convertible Debenture Agreement that allows for borrowings of up to $3,000,000 through June 2, 2016, at which time principal and interest is due in full. On June 2, 2016, the holder can elect to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company. The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.

As of December 31, 2015, the Company owed $700,000 under the agreement. Management has concluded there is currently no beneficial conversion feature associated with this instrument, as the conversion date is a year after the agreement was initiated and is also contingent. See Note 10 for amendment of this agreement subsequent to period end.

(8) LIQUIDITY AND CAPITAL REQUIREMENTS

Under the current business plan, the Company purchases life insurance policies and residual interests in or financial products tied to life insurance policies when they fit its model and its cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein the Company committed to purchase a certain number of Qualified NIBs as Del Mar made them available). The Company expects to finance NIB purchases, as well as its operating working capital requirements, with proceeds from planned public and/or private offerings of its securities and debt financing. There can be no assurance that the Company will be successful in the anticipated equity and debt offerings or that it will be successful in raising additional capital in the future on terms acceptable to the Company, or at all.

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2015

(8) LIQUIDITY AND CAPITAL REQUIREMENTS (continued)

If the Company is unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases. Under this plan, expenditures for NIBs will be curtailed. The Company believes that it will be able to fund its operating working capital requirements with existing lines-of-credit and debentures agreements.

The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. To continue as a going concern beyond the period ended December 31, 2016, and in order to continue to purchase NIBs, the Company will need to complete planned equity and debt offerings or obtain alternative sources of financing. Absent additional financing, the Company will not have the resources to execute its current business plan.

(9) STOCK OPTIONS

On July 22, 2015, the Board of Directors approved an amendment to modify the vesting schedule for stock options issued to an executive. The amendment clarified that the option to purchase 400,000 shares of the Company’s $0.001 par value common stock at $5.00 per share, with a five year term, expiring March 31, 2018, was at a vesting rate of 11,111 stock options monthly, commencing with October, 2013, and ending with September 30, 2016, subject to continued employment with the Company. As a result of this modification, the Company recorded a true-up amortization expense of $98,655 during the three months ended September 30, 2015, to adjust the amortization of the stock options to the amended vesting schedule as of the modification date of July 22, 2015. In addition, the Company adjusted the going forward quarterly amortization, beginning with the three months ended September 30, 2015, of the stock options from $73,202 to $78,728. No incremental value was applied to the amended stock options and, therefore, the original grant date fair value continues to be applicable.

(10) SUBSEQUENT EVENTS

On February 4, 2016, the Notes Payable and Lines-of-Credit Agreement – Related Party (See Note 5) was amended to allow for increased borrowings of $1,985,000. With the new increase in effect, the total borrowings allowed from the related party entities was increased from $3,245,000 to $5,230,000. All other terms of the Agreement remain in effect. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors.

On February 2, 2016, the Convertible Debenture Agreement (See note 7) was amended to extend the due date from June 2, 2016 to May 31, 2017. All other terms of the Agreement remain in effect.

Item 2. Management’s Discussions and Analysis of Financial Condition and Results of Operations.

This discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and capital resources during the three- and nine-month periods ended December 31, 2015 and 2014. For a complete understanding, this Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Financial Statements and Notes to the Financial Statements contained in this quarterly report on Form 10-Q and our annual report on Form 10-K for the year ended March 31, 2015.

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are based on management’s beliefs and assumptions and on information currently available to management. For this purpose any statement contained in this report that is not a statement of historical fact may be deemed to be forward-looking, including, but not limited to, statements relating to our future actions, intentions, plans, strategies, objectives, results of operations, cash flows and the adequacy of or need to seek additional capital resources and liquidity. Without limiting the foregoing, words such as “may”, “should”, “expect”, “project”, “plan”, “anticipate”, “believe”, “estimate”, “intend”, “budget”, “forecast”, “predict”, “potential”, “continue”, “should”, “could”, “will” or comparable terminology or the negative of such terms are intended to identify forward-looking statements; however, the absence of these words does not necessarily mean that a statement is not forward-looking. These statements by their nature involve known and unknown risks and uncertainties and other factors that may cause actual results and outcomes to differ materially depending on a variety of factors, many of which are not within our control. Such factors include, but are not limited to, economic conditions generally and in the industry in which we and our customers participate; competition within our industry; legislative requirements or changes which could render our products or services less competitive or obsolete; our failure to successfully develop new products and/or services or to anticipate current or prospective customers’ needs; price increases; employee limitations; delays, reductions, or cancellations of contracts we have previously entered into; sufficiency of working capital, capital resources and liquidity and other factors detailed herein and in our other filings with the United States Securities and Exchange Commission (the “SEC” or “Commission”). Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Forward-looking statements are predictions and not guarantees of future performance or events. Forward-looking statements are based on current industry, financial and economic information which we have assessed but which by its nature is dynamic and subject to rapid and possibly abrupt changes. Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of these forward-looking statements and we hereby qualify all our forward-looking statements by these cautionary statements.

These forward-looking statements speak only as of their dates and should not be unduly relied upon. We undertake no obligation to amend this report or revise publicly these forward-looking statements (other than pursuant to reporting obligations imposed on registrants pursuant to the Exchange Act) to reflect subsequent events or circumstances, whether as the result of new information, future events or otherwise.

The following discussion should be read in conjunction with our financial statements and the related notes contained elsewhere in this report and in our other filings with the Commission.

Overview

We are engaged in the business of purchasing or acquiring and selling life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” A life settlement is the sale of an existing life insurance policy to a third party for more than the policy’s cash surrender value, but less than the face value of the policy benefit. After the sale, the new policy holder will pay the premiums due on the policy until maturity and then collect the settlement proceeds at maturity.

We do not typically purchase or hold life insurance policies but, rather, hold a contractual right to receive the net insurance benefits (“NIBs”) from a portfolio of life insurance policies held by a third party. These NIBs represent an indirect ownership interest in a portfolio of individual life insurance policies and they allow us to receive a portion of the settlement proceeds from such policies, after expenses related to the acquisition, financing, insuring and servicing of the policies underlying our NIBs have been paid.

Our plan of operation for the next 12 months is to continue the acquisition and possible sale of NIBs. We began purchasing NIBs during our fiscal year ended March 31, 2013.

NIBs are generally sold by an entity that holds the underlying insurance policies, either directly or indirectly through a subsidiary, such an entity being referred to herein as a “Holder.” A Holder, either directly or through a wholly owned subsidiary, purchases life insurance policies either from the insured or on the secondary market and aggregates them into a portfolio of policies. At the time of purchase, the Holder also (i) contracts with a service provider to manage the servicing of the policies until maturity, (ii) purchases mortality re-insurance (“MRI”) coverage under which payments will be made to the Holder in the event the insurance policies do not mature according to actuarial life expectancies, and (iii) arranges financing to cover the initial purchase of the insurance policies, the servicing of the life insurance policies until maturity and the payment of the MRI premiums. The financing obtained by the Holder for a portfolio of insurance policies is secured by the insurance policies for which the financing was obtained. After a Holder purchases policies, aggregates them into a portfolio and arranges for the servicing, MRI coverage and financing, the Holder contracts to sell NIBs related to the policies, which gives the holder of the NIBs the right to receive the proceeds from the settlement of the insurance policies after all of the expenses related to such policies have been paid.

When an insurance policy underlying our NIBs comes to maturity, the insurance proceeds are first used to pay expenses associated with such policy. Once all of the expenses have been paid, the Holder will retain a small percentage of the proceeds and then will pay the remaining insurance proceeds to us in satisfaction of our related NIB.

Plan of Operations

Our plan of operation for the next 12 months is to continue the acquisition of NIBs. This is not a market sector without competition, and at present, we are a minor competitor. We will need substantial additional funds to effectively compete in this industry, and no assurance can be given that we will be able to adequately fund our current and intended operations, whether through revenues generated from our current interest in our NIBs or through debt or equity financing. We may be required to expend not less than approximately $113.1 million on premiums, interest and servicing costs over the next five years to protect our interest in our NIBs, though we have no legal responsibility or adequate funds for these payments. These payments are currently being made through an unrelated senior lending facility.

We currently estimate proceeds of approximately $115.3 million on the NIBs owned as of December 31, 2015, and acquired from PCH Financial S.a.r.l., a société à responsabilité limitée incorporated and existing under the laws of the Grand Duchy of Luxembourg (“PCH”), Del Mar Financial S.a.r.l., a société à responsabilité limitée incorporated and existing under the laws of the Grand Duchy of Luxembourg (“Del

Mar”) and HFII Assets Solutions, LLC, a Delaware limited liability company (“HFII”). This amount is based on the estimated proceeds from polices of approximately $401.9 million in face value, which includes estimated return of premiums; less the senior loan debt or MRI repayments outstanding of approximately $103.5 million, expected premium payments of approximately $110.2 million over the life expectancies of the insured persons in these portfolios and estimated expenses and interest of approximately $72.9 million over the term of the senior loans.

We use an estimation methodology to project cash flows and returns as presented. The estimation model required many assumptions, including, but not limited to the following: (i) an assumption that the distinct number of lives in our portfolio would exhibit similar experience to a statistically diverse portfolio based upon which the mortality tables have been created; (ii) an assumption that the life expectancies (the “LE” or “LE’s”) provided by LE providers represent the actuarial mean of the life expectancies of the insureds in our portfolio, (iii) the weighted average of the LEs provided by the LE providers represents an appropriate method for adjusting for discrepancies in the LE’s; (iv) life expectancy tables and projections are accurate; (v) the minimum premiums calculated based on the in-force illustrations provided by life insurance carriers are accurate and will not change over the course of the lifetime of our portfolio; and the senior lender fees, MRI fees, and insurance, servicing and custodial fees do not change materially over time. While this method of modeling cash flows is helpful in providing a theoretical expectation of potential returns that might be produced from our NIBs portfolio, actual cash flows and returns inevitably will be different (possibly materially) due to the fact that predicting the exact date of death of any individual is virtually impossible. The provision of a theoretical cash flow model is by no means any guarantee of any results. The actual performance of these NIB interests (as well as our future expectations as to what such performance might be) may differ substantially from our expectations, especially if any of the assumptions change or differ from our initial assumptions. These portfolios currently contain only 130 fractionalized policies on 71 individual insureds, though insurance rating agencies have stated that at least 1,000 lives are required to achieve actuarial stability. Many risk factors beyond these assumptions may result in our expectations being incorrect; therefore, no assurance can be given that these estimated results will occur.

Results of Operations

Income Recognition

Interest income on investment in NIBs represents the excess of all cash flows attributable to the investment in net insurance benefits greater than the initial investment over the life of each pool of net insurance benefits using the effective yield method. Changes in the estimate of expected cash flows from investments in NIBs are adjusted prospectively. Interest income on investment in NIBs totaled $1,090,031 and $616,547 for the three months ended December 31, 2015 and 2014, respectively. The increase is primarily due to the additional interest income generated by the additional NIBs we acquired in March and September of 2015.

Interest income on investment in NIBs totaled $2,777,500 and $1,772,698 for the nine months ended December 31, 2015 and 2014, respectively. The increase is primarily due to the additional interest income generated by the additional NIBs we acquired in March and September of 2015.

General & Administrative Expenses

General and administrative expenses totaled $1,549,676 and $526,797 during the three months ended December 31, 2015 and 2014, respectively. During the three months ended December 31, 2015, the Company accrued an $826,665 obligation which was a result of a restructuring with the prior owners of the underlying life insurance portfolios to our NIBs (See Item 1. Financial Statements, Note 4). This obligation constituted the majority of the period increase in general and administrative expenses. During the nine months ended December 31, 2015 and 2014, general and administrative expenses totaled $3,043,267 and $1,726,169, respectively. A significant portion of these expenses were professional fees, payroll and travel expenses, as well as the accrual for the claim described above.

Other Income and Expenses

Other income and expenses primarily consist of interest on the notes payable and lines-of-credits due to related-parties and a convertible debenture. During the three months ended December 31, 2015 and 2014, interest expense had accrued in the amount of $60,294 and $200,270, respectively. During the nine months ended December 31, 2015 and 2014, interest expense had accrued in the amount of $150,887 and $233,442, respectively.

Income Taxes

During the three and nine months ended December 31, 2015 and 2014, we recorded no taxable income and elected to not record deferred tax assets relating to tax net operating loss carryforwards as a result of us placing an 100% valuation allowance on our deferred tax assets.

Liquidity and Capital Resources

From our inception on January 31, 2013, through the nine months ended December 31, 2015, we incurred cumulative net losses of $868,940. Management has expressed its belief that we need to raise approximately $40 million to $50 million in additional funds through equity or debt financing to continue our business model and to effectively compete in the life settlement industry during fiscal 2016 and beyond. We raised $11,942,500 (gross) in our private placement of shares of our common stock that commenced in April 2013, and ended in November 2014. Our monthly expenses are between approximately $140,000 and $290,000, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and estimated legal and accounting expenses. We believe that by obtaining financing through equity and debt offerings, leveraging our existing notes payable and lines-of-credit, or through other alternative sources of financing, we will have adequate cash resources for our estimated monthly expenses through February 15, 2017, excluding any other acquisitions of additional NIBs and other life settlement products.

We held cash assets at December 31, 2015, and March 31, 2015, of $74,114 and $336,370, respectively. We have only common stock as our capital resource. We will be reliant upon stockholder loans or private placements of equity or debt to fund any future operations. Although management is actively pursuing opportunities to raise additional equity and debt capital, we have secured no sources of loans, and there is no assurance that we will be able to raise any required debt or equity financing. We do not anticipate having adequate revenues from operations for at least three to four years, and until a revenue stream has been established, we will require debt or equity funding to fund our current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is probable.

For the nine months ended December 31, 2015 and 2014, we recorded net cash used in operating activities of $1,590,256 and $1,406,739, respectively. During September 2015, we obtained ownership and control of a portfolio of policies due to the cancellation of the Del Mar ATA. On September 10, 2015, the Company received $1,094,335 as a result of the rights associated with a matured policy in the newly obtained portfolio. These proceeds were allocated $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar, $239,415 to pay off a note receivable (including interest) and $307,612 as a refund of advance payments previously made to or on behalf of Del Mar as part of the Del Mar ATA.

During March 2015, we agreed to pay cash, issue common stock and forgive a note receivable in exchange for relief of a $1,493,254 note payable (explained in Debt, below) and the receipt of NIBs. The net consideration given for the relief of note payable and receipt of NIBs totaled $1,493,254 and $7,846,746, respectively, for a total of $9,340,000 (of which $150,000 is cash, $150,000 is forgiveness of a note receivable and $9,040,000 is common stock consideration). Of the 1,130,000 common shares issued, 187,500 shares contained a redemption feature that required us to buy back the shares for $8 per share ($1,500,000 in total) at the option of the holder. The 1,130,000 common shares, including the 187,500 shares containing a redemption feature, were issued on June 9, 2015. On June 9, 2015, the redemption feature on 93,750 of these shares was exercised, and we paid the holders $750,000 and such 93,750 shares were cancelled. The holders of the redemption feature exercised the redemption feature on the remaining

93,750 shares on October 31, 2015, thus requiring us to pay the redemption feature, and we elected to exercise its 45 day Cure Period to make the redemption payment of $750,000 on or before December 15, 2015, in consideration of the cancellation of the remaining 93,750 shares. As a result of the redemption feature being exercised by the holder, the $750,000 associated with the redemption has been reclassified from Temporary Equity to Redeemed Common Stock Payable. To date the cure period with the holder of the redemption feature has expired. The Company and the redemption holder are negotiating the terms and conditions of an extension agreement and anticipate completion by February 15, 2016.

Net cash provided by financing activities totaled $1,117,000 and $1,422,000 for the nine months ended December 31, 2015 and 2014, respectively. During the nine months ended December 31, 2015, we drew $700,000 on an 8% Convertible Debenture dated June 2, 2015, as well as borrowed $1,167,000 from related parties, which amounts were offset by a $750,000 payment made on the exercise of the redemption feature on 93,750 common shares.

Under our current business plan, we purchase NIBs only when they fit our model and our cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein we committed to purchase a certain number of NIBs as they are made available by Del Mar). We expect to finance our NIBs purchases, as well as our operating working capital requirements, with proceeds from public and/or private offerings of our securities and debt financing. There can be no assurance that we will be successful in the anticipated equity and debt offerings or that we will be successful in raising additional capital in the future on terms acceptable to us, or at all.

If we are unable to raise sufficient capital through the equity and debt offerings or other alternative sources of financing, management will curtail NIB purchases. We believe that we will be able to fund our operating working capital requirements for at least the next 12 months through February 15, 2017, by leveraging our existing notes payable and lines-of-credit from related parties and an 8% Convertible Debenture Agreement, which together totaled $8,230,000 in available liquidity, of which $3,969,622 is available at February 9, 2016.

The accompanying financial statements have been prepared on a going concern basis under which we are expected to be able to realize our assets and satisfy our liabilities in the normal course of business. To continue as a going concern beyond the period ending February 15, 2017, and in order to continue to acquire life insurance policies and residual interests in or financial products tied to life insurance policies we will need to complete the planned securities and debt offerings or obtain alternative sources of financing. Absent additional financing, we will not have the resources to execute our business plan.

Debt

At December 31, 2015, we owed $3,476,800, including accrued interest, for debt obligations. At December 31, 2015, we held notes payable and lines-of-credits from related parties of $2,667,000, excluding accrued interest, and an 8% Convertible Debenture of $700,000, excluding accrued interest. The notes payable and Lines-of-Credit – Related Parties are due June 30, 2017, or when the Company completes a successful equity raise, at which time principal and interest is due in full, and the Convertible Debenture is due May 31, 2017. We may borrow money in the future to finance our operations, but can make no guarantees that such credit will be made available to us. Any such borrowing will increase the risk of loss to the debt holder in the event we are unsuccessful in repaying such loans.

Critical Accounting Policies and Estimates

The preparation of our financial statements requires that we make estimates and judgments. We base these on historical experience and on other assumptions that we believe to be reasonable.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosure about Market Risk

We are exposed to certain market risks in the ordinary course of business. These risks result primarily from changes in interest rates, differing economic conditions, changes in political climate, differing tax structures and other regulations and restrictions.

To date we have not utilized derivative financial instruments or derivative commodity instruments. We do not expect to employ these or other strategies to hedge market risk in the foreseeable future. Cash is held in checking, savings and money market funds, which are subject to minimal credit and market risk. We believe that the market risks associated with these financial instruments are immaterial, although there can be no guarantee that these market risks will be immaterial to us.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. Based on that evaluation, our President, who is also deemed to be our principal executive officer and our acting Chief Financial Officer (“CFO”), concluded that our disclosure controls and procedures as of the end of the period covered by the Quarterly Report were effective, and that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our President and our acting CFO, as appropriate to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system will be met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Prior to the period covered by the Quarterly Report for the period ended September 30, 2015, our President and our acting CFO, had concluded that our disclosure controls and procedures were not effective. Prior to the period ended September 30, 2015, we appointed a Chief Operating Officer and hired advisors to help us adopt new measures to improve upon our disclosure controls. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies which may be identified during this process. There were no changes to our disclosure controls during the period ended December 31, 2015.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in matters may arise from time to time that may harm our business. As of the date of this quarterly report on Form 10-Q management is not aware of any material pending legal, judicial or administrative proceedings to which the Company or any of its subsidiaries is a party or of which any properties of the Company or its subsidiaries is the subject.

Item 1A. Risk Factors

In addition to the other information set forth in this quarterly report on Form10-Q, you should carefully consider the risks discussed in our annual report on Form 10-K for the year ended March 31, 2015, and the quarterly reports on form 10-Q for the three months ended June 30, and six months ended September 30, 2015, which risks could materially affect our business, financial condition or future results. These risks are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales by us of unregistered securities during the quarter ended December 31, 2015.

Item 3. Defaults upon Senior Securities.

None; not applicable.

Item 4. Mine Safety Disclosures.

None; not applicable.

Item 5. Other Information.

As of December 31, 2015, the Company had borrowed $2,667,000 from related parties under notes payable and lines-of-credit agreements that allows for borrowings of up to $3,245,000 through the earlier of June 30, 2017, or when the Company completes a successful equity raise, at which time principal and interest is due in full. On February 4, 2016, the notes payable and lines-of-credit agreements were amended to allow for increased borrowings of $1,985,000. With the new increase in effect, the total borrowings allowed from the related party entities was increased from $3,245,000 to $5,230,000. All other terms of the agreements remain in effect. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors.

On June 2, 2015, the Company entered into an 8% convertible debenture agreement that allowed for borrowings of up to $3,000,000 through June 2, 2016, at which time principal and interest was to be due in full. On February 2, 2016, the convertible debenture agreement was amended to extend the due date from June 2, 2016 to May 31, 2017. All other terms of the Agreement remain in effect.

Item 6. Exhibits

Exhibits. The following exhibits are included as part of this report:

	Exhibit 10.1		Amendment to the notes payable and lines-of-credit agreements, dated February 4, 2016, between the Company, Kraig Higginson and Radiant Life, LLC

	Exhibit 10.2		Amendment to the convertible debenture agreement, dated February 2, 2016, between the Company and Sactco International, Limited.

	Exhibit 31.1		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, President and Director.

	Exhibit 31.2		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, acting CFO.

	Exhibit 32		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 proved by Randall F. Pearson, President and acting CFO.

	Exhibit 101.INS		XBRL Instance Document

	Exhibit 101.SCH		XBRL Taxonomy Extension Schema Document

	Exhibit 101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

	Exhibit 101.DEF		XBRL Taxonomy Definition Linkbase Document

	Exhibit 101.LAB		XBRL Taxonomy Extension Label Linkbase Document

	Exhibit 101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

EX-10.1 2 ex10_1.htm AMENDMENT TO THE NOTES PAYABLE AND LINES-OF-CREDIT AGREEMENTS, DATED FEBRUARY 4, 2016, BETWEEN THE COMPANY, KRAIG HIGGINSON AND RADIANT LIFE, LLC ex10_1.htm

EXHIBIT 10.1

Additions To Kraig T. Higginson Promissory Note

Reference is made to the Promissory note by and between the undersigned parties, Sundance Strategies, Inc. and Kraig T. Higginson, said note originally dated July 22, 2015, subsequently extended to June 30,2017.

Be it known, that for good consideration the parties made the following additions or changes to said contract as if contained therein:

1. Total amount of the promissory note to be increased to an amount not to

exceed $3,100,000.

2. The total to date received by Sundance Strategies from Kraig Higginson is

$2,060,377.62.

All other terms and provisions shall remain in full force and effect.

Sundance Strategies, Inc.

/s/ Randall F. Pearson

By: Randall F. Pearson, It’s President

Signed this 4th day of February, 2016.

Kraig T. Higginson

/s/ Kraig T. Higginson

By: Kraig T. Higginson

Signed this 4th day of February, 2016.

EX-10.2 3 ex10_2.htm AMENDMENT TO THE CONVERTIBLE DEBENTURE AGREEMENT, DATED FEBRUARY 2, 2016, BETWEEN THE COMPANY AND SACTCO INTERNATIONAL, LIMITED ex10_2.htm

EXHIBIT 10.2

February 1, 2016

Regarding: Debenture agreement between Sundance

Strategies, Inc. and Satco Internationat Limited.

I agree to extend the Debenture Agreement between Satco and Sundance Strategies, Inc. from the original due date of June 2, 2016 to May 31, 2017. All other terms and conditions remain the same.

/s/ Stephen H. Smoot	February 1, 2016
Stephen H. Smoot	Date
Satco Internationat Limited
Attorney-in-Fact

/s/ Randall F. Pearson	February 2, 2016
Randall F. Pearson	Date
President
Sundance Strategies, Inc.

EX-31.1 4 ex31_1.htm CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT PROVIDED BY RANDALL F. PEARSON, PRESIDENT AND DIRECTOR ex31_1.htm

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Randall F. Pearson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sundance Strategies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-31.2 5 ex31_2.htm CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT PROVIDED BY RANDALL F. PEARSON, ACTING CFO ex31_2.htm

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Randall F. Pearson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sundance Strategies, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-32.1 6 ex32_1.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 PROVED BY RANDALL F. PEARSON, PRESIDENT AND ACTING CFO ex32_1.htm

EXHIBIT 32

CERTIFICATION OF PRINCIPAL

EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Sundance Strategies, Inc. (the “Company”) for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Randall F. Pearson, Chief Executive Officer and cting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-101.INS 7 sund-20151231.xml 0001171838 2015-12-31 0001171838 2015-03-31 0001171838 2015-04-01 2015-12-31 0001171838 2014-04-01 2014-12-31 0001171838 2014-03-31 0001171838 2014-12-31 0001171838 2015-05-31 0001171838 2015-06-01 2015-06-30 0001171838 2015-06-08 2015-06-09 0001171838 us-gaap:EmployeeStockOptionMember 2015-07-21 2015-07-22 0001171838 us-gaap:EmployeeStockOptionMember 2015-07-22 0001171838 2014-04-01 2015-03-31 0001171838 sund:StockholderMember 2015-12-31 0001171838 sund:StockholderMember 2015-04-01 2015-12-31 0001171838 2015-10-01 2015-12-31 0001171838 2014-10-01 2014-12-31 0001171838 us-gaap:MaximumMember 2015-12-31 0001171838 us-gaap:MinimumMember 2015-12-31 0001171838 2015-08-31 0001171838 2015-09-09 2015-09-10 0001171838 sund:NIBCollateralizedNotePayableMember 2014-03-31 0001171838 sund:NIBCollateralizedNotePayableMember 2015-03-31 0001171838 sund:NIBCollateralizedNotePayableMember 2014-04-01 2015-03-31 0001171838 sund:NIBCollateralizedNotePayableMember 2015-04-01 2015-06-30 0001171838 2016-02-05 0001171838 2015-09-30 0001171838 2015-07-01 2015-09-30 0001171838 us-gaap:ScenarioPreviouslyReportedMember 2015-07-01 2015-09-30 0001171838 sund:StockholderMember us-gaap:SubsequentEventMember 2016-02-04 0001171838 sund:StockholderMember us-gaap:SubsequentEventMember 2016-02-03 2016-02-04 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure sund:item

77864

338245

28690516

22544635

3596386

211000

16428

28690516

26368449

28768380

26706694

279128

255361

826665

181917

1326876

1500000

1855793

3264154

5332593

3264154

10000000

0.001

500000000

0.001

44222191

43185941

44222

43186

24260505

16316882

7540000

-868940

-457528

23435787

23442540

28768380

74114

26706694

336370

3750

1875

2667000

700000

109800

3476800

0.001

44222191

10000000

500000000

0.001

43185941

2777501

1772698

3043267

1726169

-265766

46529

5241

13388

150887

233442

6303

-145646

-213751

-411412

-167222

-411412

-167222

-0.01

43122354

44029347

1090031

616547

1549676

526797

-459645

89750

4568

60294

200270

-60294

-195702

-519939

-105952

-519939

-105952

-0.01

44315941

43185941

404659

320333

626914

794598

-16428

4847

1875

1750

23767

75339

927672

34430

-1590256

-1406739

-211000

-550000

211000

400000

1167000

1272000

1117000

1422000

-262256

415261

375212

790473

100000

700000

750000

1500000

150000

854920 904274

2777501

1772698

3368380

94000000 10000000 84000000 0.81

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (2) NEW ACCOUNTING PRONOUNCEMENTS   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2014-09 Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The Company is currently evaluating the guidance, including which transition approach will be applied and the estimated impact it will have on our consolidated financial statements. The Company does not believe adoption of this ASU will have a material impact on its financial statements. In August 2014, the FASB issued ASU 2014-15 Presentation of Financial StatementsGoing Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern.   The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements. In April, 2015, the FASB issued ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs (Subtopic 835-30). This update requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. Under current standards, debt issuance costs are generally recorded as an asset and amortization of these deferred financing costs is recorded in interest expense. Under the new standard, debt issuance costs will continue to be amortized over the life of the debt instrument and amortization will continue to be recorded in interest expense. ASU 2015-03 is effective for the Company on April 1, 2016, and will be applied on a retrospective basis. In May 2015, the FASB issued ASU 2015-08, Business Combinations (Topic 805): Pushdown Accounting. This Accounting Standards Update amends various SEC paragraphs pursuant to the issuance of Staff Accounting Bulletin No.115. The Company notes the Update is effective immediately and will apply to the Company if the Company acquires a business. In August 2015, the FASB issued ASU 2015-15, Interest-Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. This Update was issued to make some fairly minor wording adjustments to ASC 835-30. The new wording, presented as paragraph 835-30-S45-1, recognizes that ASU 2015-13 does not address the presentation and subsequent measurement of debt issuance costs related to line-of-credit arrangements. As stated below, ASU 2015-13 requires companies to recognize debt issuance costs as a reduction of the carrying amount of the associated debt liability. ASU 2015-15 states that debt issuance costs related to line-of-credit arrangements may be recognized as an asset and amortized over the term of the line-of-credit arrangement, even if the line-of-credit does not carry a balance. The Company notes that this guidance does apply to its reporting requirements and will implement the new guidance accordingly. In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. This Update, which is part of the FASB's larger Simplification Initiative project aimed at reducing the cost and complexity of certain areas of the accounting codification, requires that an acquirer recognize adjustments to provisional amounts identified during the measurement period in the reporting period in which the adjustment amounts are determined. Furthermore, the acquirer should record in the same period's financial statements, the effect on earnings from any changes in depreciation, amortization or other items impacting income. These changes resulting from adjustments to provisional amounts should be calculated as if the accounting had been completed at the actual acquisition date. Lastly, the Update requires the acquirer to present separately on the face of the income statement or in the footnote disclosures the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the actual acquisition date. This Update is effective for fiscal years beginning after December 15, 2016. The amendments in this Update should be applied prospectively to adjustments to provisional amounts that occur after the effective date of this Update, with earlier application permitted. The amendments are effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. All entities have the option of adopting the new requirements as of an earlier date for financial statements that have not been previously issued. Applicable disclosures for a change in an accounting principle are required in the year of adoption, including interim periods. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. The Company notes that this guidance may apply to its reporting requirements and will implement the new guidance accordingly. In November 2015, the FASB issued ASU 2015-17 regarding Balance Sheet Classification of Deferred Taxes, which simplifies the presentation of deferred income taxes by requiring all deferred income tax liabilities and assets be classified as noncurrent on the consolidated balance sheets. The guidance is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2016, with early adoption permitted. The standard would be effective for the Company's fiscal year beginning April 1, 2017, however, we expect to early adopt the provisions of this standard effective January 1, 2016 on a prospective basis. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements.   In January 2016, the FASB issued ASI 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company's fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements. </div>

1094335 547308 239415 307612 3368380

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> <div style="display: block;"> <div style="display: block;"> <div style="display: block;"> (4) INVESTMENT IN NET INSURANCE BENEFITS   Investment in NIBs for the nine months ended December 31, 2015, and the fiscal year ended March 31, 2015, were as follows:   <div> <div align="center"> <div class="CursorPointer"> <table style="border-collapse: collapse; width: 80%; margin-left: 0.100000001490116px; margin-right: 0.1px;" cellspacing="0" cellpadding="0"> <tr> <td style="background-color: #ffffff; vertical-align: middle; font-family: 'times new roman'; padding: 0px;"></td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> December 31, 2015 </td> <td style="background-color: #ffffff; vertical-align: middle; text-align: center; font-family: 'times new roman'; padding: 0px;" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> March 31, 2015 </td> </tr> <tr> <td style="vertical-align: middle; padding: 0px; font-family: 'Times New Roman'; width: 69%; background-color: #ffffff;"> Beginning Balance </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left">$</td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">22,544,635 </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"></td> <td style="vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left">$</td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">12,243,411</td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"></td> </tr> <tr> <td style="vertical-align: middle; padding: 0px; font-family: 'Times New Roman'; width: 69%; background-color: #ffffff;"> Additional investments </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">                        3,368,380 </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">7,846,746</td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Accretion of interest income </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                        2,777,501 </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">2,454,478</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Distributions of investments </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                  - </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">-</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Impairment of investments </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                - </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">-</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Total </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">28,690,516 </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">22,544,635</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> </table> </div> </div> </div>   As mentioned in Note 3, the Company transferred $3,368,380 from advance for investment in NIBs into investment in NIBs on September 30, 2015.   The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (MRI). Future expected cash flow is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment and service provider or other third-party payments. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2015. The Company holds between 81% and 100% in the NIBs relating to the underlying life insurance policies as of December 31, 2015.    The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations. Subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows that does not result in the recognition of an other-than-temporary impairment (OTTI) results in a prospective increase or decrease in the effective interest rate used to recognize interest income. We have not recognized any significant adverse change in future estimated cash flows relating to our investment in NIBs from January 31, 2013 (inception) to the period ended December 31, 2015.   During July, 2015, a group of persons located in the United States (the Purchasers) acquired the entities that owned all of the portfolios of life insurance contracts underlying the Company's NIBs. The Purchasers have also agreed to amend the NIBs agreements to provide greater disclosure to the Company and limit permitted expenses to be paid prior to payments to the NIBs holders, pending certain regulatory and tax approvals. In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a Settlement Agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts. The Purchasers further required releases from the Company and the payment of certain accrued expenses. Accordingly, effective as of July 17, 2015, the Purchasers acquired all of the ownership interests in the entities that owned all of the portfolios of life insurance contracts underlying the Company's NIBs from their prior owners and executed a Settlement Agreement with such owners and the Company in relation to these matters. The NIBs amendments are in process, and the Company believes the NIBs amendments will be in effect within the next three months. The Company and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership or management of the entities sold, based on actions that occurred prior to this sale to the Purchasers. During the three months ended December 31, 2015, the Company accrued for an $826,665 obligation related to the ownership change, which is recorded in General and Administrative Expenses. Management of the Company is presently not aware of the existence of any additional payments owed. Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in our NIBs ownership interest. The Company was supportive of the Purchasers acquiring the entities that owned the portfolios of life insurance contracts underlying the Company's NIBs and was willing to provide the indemnification because it believes this ownership change will result in a reduction of costs and expenses associated with ownership of the NIBs, which should increase their intrinsic value. </div> </div> </div> </div> </div>

12243411

3368380

7846746

2454478

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div align="center"> <div class="CursorPointer"> <table style="border-collapse: collapse; width: 80%; margin-left: 0.100000001490116px; margin-right: 0.1px;" cellspacing="0" cellpadding="0"> <tr> <td style="background-color: #ffffff; vertical-align: middle; font-family: 'times new roman'; padding: 0px;"></td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> December 31, 2015 </td> <td style="background-color: #ffffff; vertical-align: middle; text-align: center; font-family: 'times new roman'; padding: 0px;" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"> </td> <td style="background-color: #ffffff; vertical-align: middle; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> March 31, 2015 </td> </tr> <tr> <td style="vertical-align: middle; padding: 0px; font-family: 'Times New Roman'; width: 69%; background-color: #ffffff;"> Beginning Balance </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left">$</td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">22,544,635 </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"></td> <td style="vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left">$</td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">12,243,411</td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"></td> </tr> <tr> <td style="vertical-align: middle; padding: 0px; font-family: 'Times New Roman'; width: 69%; background-color: #ffffff;"> Additional investments </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">                        3,368,380 </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: middle; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;"> </td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 12%; background-color: #ffffff;" align="right">7,846,746</td> <td style="vertical-align: bottom; padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; width: 1%; background-color: #ffffff;" align="left"> </td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Accretion of interest income </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                        2,777,501 </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">2,454,478</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"> </td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Distributions of investments </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                  - </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">-</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Impairment of investments </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">                - </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">-</td> <td style="background-color: #ffffff; vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; font-family: 'Times New Roman';"> Total </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">28,690,516 </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="background-color: #ffffff; vertical-align: middle; text-align: right; font-family: 'times new roman'; padding: 0px;"> </td> <td style="background-color: #ffffff; vertical-align: middle; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" align="right">22,544,635</td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: #000000 2.80pt double !important; border-top: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> </table> </div> </div> </div> 1.00 1.00 0.81 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS On June 7, 2013, the Company entered into an Asset Transfer Agreement (the Del Mar ATA) with Del Mar Financial, S.a.r.l. (Del Mar). As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the Europa Agreement and Europa).   The Del Mar ATA involved the purchase of certain life settlement assets consisting of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the NIBs), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. According to the Del Mar ATA, Del Mar, with the assistance of Europa, was obligated to convert the NIBs and other newly acquired NIBs into Qualified NIBS. As soon as Del Mar met its obligation to provide Qualified NIBs to the Company, any remaining NIBs and any other consideration and collateral would be returned or released to Del Mar. The original due date for the conversion was December 31, 2013, which date was subsequently extended several times. On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related Europa Agreement to extend the deadline until August 31, 2015.   The remaining consideration and collateral under the Del Mar ATA, as of September 1, 2015, primarily consisted of approximately 81% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. During June 2015, one of the life settlement policies matured for $10,000,000 (the Matured Policy), lowering the remaining face value of such life settlement policies to $84,000,000. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a senior lender.    As Del Mar was unable to provide the required amount of Qualified NIBs by the extended due date of August 31, 2015, effective September 1, 2015, the agreements with Del Mar and Europa were cancelled and the Company obtained full ownership and control of the collateral, which included the above mentioned approximately 81% of the NIBs associated with the $84,000,000 face value of life settlement policies and certain rights to net proceeds relating to the Matured Policy.   The bulk of the $10,000,000 proceeds paid in connection with the Matured Policy were used to repay loans secured by such Matured Policy. However, on September 10, 2015, the Company received $1,094,335 as a result of the rights associated with the Matured Policy. These proceeds were allocated $239,415 to pay off a note receivable (including interest), $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar and $307,612 as a refund of advance payments previously made to or on behalf of Del Mar as part of the Del Mar ATA. The $547,308 and $307,612 proceeds, which together total $854,920, were applied to reduce Advance for Investment in NIBs.   On September 30, 2015, the Company transferred the remaining balance of advances and expense payments to Del Mar, totaling $3,368,380, which approximates fair value. This amount was residing in advance for investment in NIBs before being transferred to investment in NIBs (see Note 4).   In addition to obtaining full and unrestricted rights to the NIBs upon termination of the Del Mar ATA and Europa Agreement, the Company also is entitled to receive liquidated damages from Del Mar in an amount equal to 100% of any cash advances made under the Del Mar ATA. The Company is currently determining the extent of the liquidated damages claim and Del Mar's ability to pay any such liquidated damages. <font style="font-size: 10.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">The liquidated damages are computed pro rata, based upon the percentage of Qualified NIBs delivered by Del Mar under the Del Mar ATA.  The Company received $90,600,000 in Qualified NIBs or approximately 22.65% of the $400,000,000 in Qualified NIBs due under the Del Mar ATA.  Accordingly, once 22.65% of its costs and expenses are deducted, the Company would be entitled to receive the remaining amount of its costs and expenses, times two, as liquidated damages. As a result of the termination, the Company has no further payment obligations to Del Mar or fee obligations to Europa. The Company is determining whether Europa is liable to the Company for any damages related to Del Mar's failure to provide the required Qualified NIBs.   The liquidated damages claim is secured by all of the assets transferred to the Company under the Del Mar ATA and a Collateral Pledge Agreement executed by Del Mar on June 5, 2013, pledging all of Del Mar's remaining assets to the Company unless and until Del Mar completes all of its obligations under the Del Mar ATA. The Company is unsure what, if any, assets are currently held by Del Mar. </div> 1.00 90600000 0.2265 400000000

2667000

0.075

3245000

1367000

200000

1455904

37350

0.04

187500

2015-04-01

93750

750000

P5Y

11111 98655 73202 78728 Sundance Strategies, Inc. 0001171838 10-Q <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (8)  LIQUIDITY AND CAPITAL REQUIREMENTS      Under the current business plan, the Company purchases life insurance policies and residual interests in or financial products tied to life insurance policies when they fit its model and its cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein the Company committed to purchase a certain number of Qualified NIBs as Del Mar made them available). The Company expects to finance NIB purchases, as well as its operating working capital requirements, with proceeds from planned public and/or private offerings of its securities and debt financing. There can be no assurance that the Company will be successful in the anticipated equity and debt offerings or that it will be successful in raising additional capital in the future on terms acceptable to the Company, or at all. If the Company is unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases. Under this plan, expenditures for NIBs will be curtailed. The Company believes that it will be able to fund its operating working capital requirements with existing lines-of-credit and debentures agreements. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. To continue as a going concern beyond the period ended December 31, 2016, and in order to continue to purchase NIBs, the Company will need to complete planned equity and debt offerings or obtain alternative sources of financing. Absent additional financing, the Company will not have the resources to execute its current business plan. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (9) STOCK OPTIONS   On July 22, 2015, the Board of Directors approved an amendment to modify the vesting schedule for stock options issued to an executive.  The amendment clarified that the option to purchase 400,000 shares of the Company's $0.001 par value common stock at $5.00 per share, with a five year term, expiring March 31, 2018, was at a vesting rate of 11,111 stock options monthly, commencing with October, 2013, and ending with September 30, 2016, subject to continued employment with the Company. As a result of this modification, the Company recorded a true-up amortization expense of $98,655 during the three months ended September 30, 2015, to adjust the amortization of the stock options to the amended vesting schedule as of the modification date of July 22, 2015.  In addition, the Company adjusted the going forward quarterly amortization, beginning with the three months ended September 30, 2015, of the stock options from $73,202 to $78,728.  No incremental value was applied to the amended stock options and, therefore, the original grant date fair value continues to be applicable. </div>

400000

0.001

5.00

2015-12-31 --03-31 44315941 2016 Q3 Accelerated Filer false

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (7) CONVERTIBLE DEBENTURE AGREEMENT   On June 2, 2015, the Company entered into an 8% Convertible Debenture Agreement that allows for borrowings of up to $3,000,000 through June 2, 2016, at which time principal and interest is due in full. On June 2, 2016, the holder can elect to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company. The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share. As of December 31, 2015, the Company owed $700,000 under the agreement. Management has concluded there is currently no beneficial conversion feature associated with this instrument, as the conversion date is a year after the agreement was initiated and is also contingent. See Note 10 for amendment of this agreement subsequent to period end. </div>

0.08 3000000 700000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received</div> 1.00

150000

81621

1500

750000

1985000

5230000

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> (10) SUBSEQUENT EVENTS On February 4, 2016, the Notes Payable and Lines-of-Credit Agreement Related Party (See Note 5) was amended to allow for increased borrowings of $1,985,000. With the new increase in effect, the total borrowings allowed from the related party entities was increased from $3,245,000 to $5,230,000. All other terms of the Agreement remain in effect. The related parties include a person who is the Chairman of the Board of Directors and a stockholder and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. On February 2, 2016, the Convertible Debenture Agreement (See note 7) was amended to extend the due date from June 2, 2016 to May 31, 2017. All other terms of the Agreement remain in effect. </div>

EX-101.SCH 8 sund-20151231.xsd 001 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 80000 - Disclosure - CORRECTION OF AN ERROR RELATED TO THE ADOPTION OF AN ACCOUNTING PRINCIPLE link:presentationLink link:calculationLink link:definitionLink 102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 104 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS link:presentationLink link:calculationLink link:definitionLink 103 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS link:presentationLink link:calculationLink link:definitionLink 106 - Disclosure - NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE link:presentationLink link:calculationLink link:definitionLink 109 - Disclosure - STOCK OPTIONS link:presentationLink link:calculationLink link:definitionLink 113 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 114 - Disclosure - STOCK TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 80300 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 110 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) link:presentationLink link:calculationLink link:definitionLink 304 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 309 - Disclosure - PROVISION FOR INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 312 - Disclosure - STOCK OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 313 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Investment in Net Insurance Benefit Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 40404 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Future Estimated Premiums Payments, Other Expenses and Interest Paid By External Parties) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 80701 - Disclosure - NOTE RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - PROVISION FOR INCOME TAXES (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - PROVISION FOR INCOME TAXES (Schedule of Net Deferred Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 80500 - Disclosure - RELATED PARTY PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - STOCK OPTIONS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - STOCK OPTIONS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - WARRANTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - WARRANTS (Schedule of Warrant Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 105 - Disclosure - NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 306 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Investment in Net Insurance Benefit Contracts Held As Collateral) (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Future Estimated Premiums Payments, Other Expenses and Interest Paid) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (Details) link:presentationLink link:calculationLink link:definitionLink 108 - Disclosure - LIQUIDITY AND CAPITAL REQUIREMENTS link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - CONVERTIBLE DEBENTURE AGREEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 107 - Disclosure - CONVERTIBLE DEBENTURE AGREEMENT link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 sund-20151231_cal.xml EX-101.DEF 10 sund-20151231_def.xml EX-101.LAB 11 sund-20151231_lab.xml Additional paid in capital adjustment for stock to be issued. Additional Paid In Capital Stock To Be Issued Additional Paid In Capital- Stock to be Issued Summary of investments in net insurance benefits. Summary Of Life Settlement Contracts [Table Text Block] Summary of Investments in Net Insurance Benefits Tabular disclosure of the future estimated premiums payments, other expenses and interest paid by external parties expected to be paid on the policies through the estimated death date, future cash flows to investors, as well as future estimated proceeds from policy maturities for insurance benefit contracts. Schedule Of Future Estimated Premiums Paymenst And Other Expenses Expected To Be Paid On Insurance Benefit Contracts [Table Text Block] Schedule of Future Estimated Premiums, Payments and Other Expenses Expected to be Paid on Insurance Benefit Contracts Schedule of Estimated Premiums, Payments and Other Expenses Expected to be Paid on Insurance Benefit Contracts Held as Collateral Distributions of life settlement contract investments. Distribution Of Life Settlement Contract Investments Distributions of investments Amount of life insurance expense and interest anticipated to be paid in the next fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest In Next Twelve Months Expense + Interest to be paid, year one Amount of life insurance premiums, expense, and interest anticipated to be paid in the next fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Next Twelve Months Total to be paid, year one Amount of life insurance expense and interest anticipated to be paid in the second fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Two Expense + Interest to be paid, year two Amount of life insurance premiums, expense, and interest anticipated to be paid in the second fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Two Total to be paid, year two Amount of life insurance expense and interest anticipated to be paid in the third fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Three Expense + Interest to be paid, year three Amount of life insurance premiums, expense, and interest anticipated to be paid in the third fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Three Total to be paid, year three Amendment Flag Amount of life insurance expense and interest anticipated to be paid in the fourth fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Four Expense + Interest to be paid, year four Amount of life insurance premiums, expense, and interest anticipated to be paid in the fourth fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Four Total to be paid, year four Amount of life insurance expense and interest anticipated to be paid in the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Five Expense + Interest to be paid, year five Amount of life insurance premiums, expense, and interest anticipated to be paid in the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Five Total to be paid, year five Total amount of life insurance expense and interest anticipated to be paid to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Total Expense + Interest, total Amount of life insurance premiums, expense and interest anticipated to be paid to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid Premiums, interest and expenses, total The capitalized cost of fee paid to the consultant for arranging purchase of net insurance benefits through pledge agreement. Capitalized Consultant Fee Capitalized consultant fee Amount of life settlement contracts that matured during the period. Life Settlement Contracts Matured During Period Contracts that matured during the period Total amount the policy holders have paid on policy premiums and other expenses on the insurance contracts. Life Settlement Contracts Investment Method Premiums Paid And Other Expenses Total amount policy holders have paid on policy premiums and other expenses on insurance contracts The face value of net insurance benefits purchased under asset transfer agreement. Face Value Of Net Insurance Benefits Purchased Under Asset Transfer Agreement Face value of net insurance benefits purchased under asset transfer agreement The value of qualified net insurance benefits required to be delivered to the company per the asset transfer agreement. Value Of Qualified Net Insurance Benefits Qualified net insurance benefits received The total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement. Total Cash Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement Total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. The face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement. Total Notes Payable That Would Be Issued By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement Face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. The entire disclosure for advances for investments in net insurance benefits. Advance For Investment In Net Insurance Benefits [Text Block] ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS Face amount of net insurance benefits required to be delivered to the company per the asset transfer agreement. Value Of Net Insurance Benefits Required To Be Delivered Per Asset Transfer Agreement Face amount of net insurance benefits required to be delivered to the company per the asset transfer agreement Required amount of qualified NIBs under the Del Mar ATA The amount advanced to consultant for services under exclusivity agreement. Advance To Consultant For Services Advance to consultant for services Current Fiscal Year End Date Interest rate on notes receivable. Notes Receivable Interest Rate Interest rate Del Mar [Member] Del Mar [Member] Majestic [Member] Majestic [Member] Warrant Term Warrant Term Notes Receivable Maturity Date Maturity date Office One [Member] Office One [Member] Utah Office [Member] Office Two [Member] Office Two [Member] California Office [Member] Award Date One [Member] Award Date One [Member] April 1, 2013 [Member] Number of shares that vest upon grant. Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights On Grant Date Amount Shares vesting on grant date Document Period End Date Number of shares that vest equally on the anniversary of the grant date for the vesting period. Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights On Anniversary Date Amount Shares vesting on each anniversary Number of shares vesting in equal groups. Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Equally Shares vesting equally Award Date Two [Member] Award Date Two [Member] April 5, 2013 [Member] Tranche One [Member] Tranche One [Member] Award Date [Axis] Tranche Two [Member] Tranche Two [Member] Award Type [Axis] Share based compensation issued to nonemployees. Nonemployees [Member] Award Date [Domain] Award Date Three [Member] October 11, 2013 [Member] The weighted average grant-date fair value of options outstanding during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding at end of period Outstanding at beginning of period Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term 2 Granted Entity [Domain] The weighted average grant-date fair value of options exercised during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value Exercised Weighted average remaining contractual term for option awards exercised, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term 2 Exercised The weighted average grant-date fair value of options forfeited during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures Weighted Average Grant Date Fair Value Cancelled/Expired The amount of investment in a private offering of common stock. Private Placement Investment Amount Private placement investment amount Number of warrants authorized for issuance. Class Of Warrant Or Right Number Of Warrants Authorized For Issuance Number of warrants authorized for issuance A non cash financing activity incurred directly from the issuance of warrants. Fair Value Of Warrants Issued Stock Issuance Costs Fair Value of Warrants Issued as Stock Issuance Costs Warrants and rights note disclosure text block Warrants And Rights Note Disclosure Text Block WARRANTS Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options outstanding. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Exercise Price Outstanding at end of period Outstanding at beginning of period Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price Granted Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Weighted Average Remaining Contractual Terms Granted The grant-date intrinsic value of equity instruments other than options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value Extended Granted Weighted average price under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price Forfeitures Cancelled/Expired Weighted average remaining contractual term for equity-based awards excluding options forfeited, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Remaining Contractual Terms Cancelled/Expired The intrinsic value of equity instruments other than options cancelled or expired during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Or Expired In Period Intrinsic Value Cancelled/Expired Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Exercise Price Exercisable Weighted average remaining contractual term for equity-based awards excluding options exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms Exercisable Represents the information pertaining to common stock to be issued. Common Stock To Be Issued [Member] Represents the amount of refund of advance for investments in net insurance benefits. Refund of Advance for Investments in Net Insurance Benefits Refund of Advance for Investments in Net Insurance Benefits Proceeds allocated to reduce advance for Investments in NIBs Proceeds allocated to reduce advance for Investments in NIBs Advance For Investment In Net Insurance Benefits [Abstract] ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract] The amount advanced in payments under the Del Mar ATA. Amount Of Payments Advanced Under Ata Agreement Advanced payments under the Del Mar ATA Anew Acquisition Corp [Member] Anew Acquisition Corp [Member] Merger Subsidiary [Member] Reverse merger and recapitalization with ANEW LIFE INC. Anew Life [Member] ANEW LIFE [Member] The amount of buyback option per loan agreement. Buyback Option Amount Buyback option The percentage amount of additional cost added to buyback amount for everymonth past the twelve month period. Buyback Option Amount Additional Percentage Buyback amount, added monthly percentage The minimim price threshold for buyback option. Buyback Option Minimum Price Minimum buyback price The time period from assigment of ammended note to buyback. Buyback Option Period Buyback period Document And Entity Information [Abstract] GOING CONCERN [Abstract] Life insurance policies purchased with debt. Life Insurance Policies Purchased With Debt Net Insurance Benefits Purchased with Debt Amount of life insurance expense and interest anticipated to be paid after the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid After Year Five Expense + Interst to be paid, thereafter Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Fiscal Year Maturity [Abstract] Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Fiscal Year Maturity [Abstract] Expenses + Interest: Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid [Abstract] Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid [Abstract] Total Premiums, Interest and Expenses: Amount of life insurance premiums, expense and interest anticipated to be paid after the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid After Year Five Total to be paid, thereafter Amount of cash paid for the net insurance benefits purchased through pledge agreement. Life Settlement Contracts Portion Of Pledge Agreement Paid In Cash Amount of cash paid for the net insurance benefits purchased through pledge agreement Face value of net insurance benefits purchased through pledge agreement. Life Settlement Contracts Purchased Through Pledge Agreement Face value of net insurance benefits purchased through pledge agreement First related party transaction. Related Party Transaction One [Member] January 8, 2014 [Member] Second related party transaction. Related Party Transaction Two [Member] January 13, 2014 [Member] Return of premium provisions on investments in net insurance benefits. Return Of Premium Provisions On Life Settlement Contracts Return of premium provisions on investments in net insurance benefits Ownership interest held by former shareholders of acquiree. Reverse Merger Shareholder Equity Interests Reverse merger, equity interests held by former shareholders Entity Well-known Seasoned Issuer Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Entity Voluntary Filers Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value [Abstract] Intrinsic Value Entity Current Reporting Status Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Entity Filer Category The terms of Structuring and Consulting Agreement. Structuring And Consulting Agreement Terms Structuring and Consulting Agreement, terms Entity Public Float The total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement. Total Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement Total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. Entity Registrant Name Entity Central Index Key Tabular disclosure of life settlement contracts held as collateral based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate including: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, and (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented. Schedule of Life Settlement Contracts Investment Method Held as Collateral [Text Block] Schedule of Investments in Net Insurance Benefit Contracts Held As Collateral Number of life settlement contracts held as collateral accounted for under the investment method maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Life Settlement Contracts Investment Method Number of Contracts Held As Collateral Maturing in Next Twelve Months Number of interests in life settlement contracts, next twelve months, held as collateral Number of life settlement contracts held as collateral accounted for under the investment method maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Life Settlement Contracts Investment Method Number of Contracts Held as Collateral Maturing In Year Two Number of interests in life settlement contracts, year two, held as collateral Number of life settlement contracts held as collateral accounted for under the investment method maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Life Settlement Contracts Investment Method Number of Contracts Held as Collateral Maturing in Year Three Number of interests in life settlement contracts, year three, held as collateral Entity Common Stock, Shares Outstanding Number of life settlement contracts held as collateral accounted for under the investment method maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Life Settlement Contracts Investment Method Number of Contracts Held as Collateral Maturing in Year Number of interests in life settlement contracts, year four, held as collateral EX-101.PRE 12 sund-20151231_pre.xml XML 13 R1.htm IDEA: XBRL DOCUMENT

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
DOCUMENT AND ENTITY INFORMATION - shares	Dec. 31, 2015	Feb. 05, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Entity Registrant Name	Sundance Strategies, Inc.
Entity Central Index Key	0001171838
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		44,315,941

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Mar. 31, 2015
Current Assets
Cash and Cash Equivalents	$ 74,114	$ 336,370
Prepaid Expenses	3,750	1,875
Total Current Assets	77,864	338,245
Other Assets
Investment in Net Insurance Benefits	$ 28,690,516	22,544,635
Advance for Investment in Net Insurance Benefits		3,596,386
Notes Receivable		211,000
Other		16,428
Total Other Long-term Assets	$ 28,690,516	26,368,449
Total Assets	28,768,380	26,706,694
Current Liabilities
Accounts Payable	279,128	255,361
Accrued Expenses	$ 826,665	181,917
Notes Payable		1,326,876
Note Payable-Related Party		$ 1,500,000
Redeemed Common Stock Payable	$ 750,000
Total Current Liabilities	1,855,793	$ 3,264,154
Long-Term Liabilities
Note Payable-Related Party	2,667,000
Convertible Debenture	700,000
Accrued Expenses	109,800
Total Long-Term Liabilities	3,476,800
Total Liabilities	$ 5,332,593	$ 3,264,154
Stockholders' Equity
Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common Stock, authorized 500,000,000 shares, par value $0.001; 44,222,191 and 43,185,941 shares issued and outstanding, respectively	$ 44,222	$ 43,186
Additional Paid In Capital	$ 24,260,505	16,316,882
Additional Paid In Capital- Stock to be Issued		7,540,000
Accumulated Deficit	$ (868,940)	(457,528)
Total Stockholders' Equity	23,435,787	23,442,540
Total Liabilities and Stockholders' Equity	$ 28,768,380	$ 26,706,694

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Mar. 31, 2015
Condensed Consolidated Balance Sheets [Abstract]
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	44,222,191	43,185,941
Common Stock, shares outstanding	44,222,191	43,185,941

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Condensed Consolidated Statements of Operations [Abstract]
Interest Income on Investment in Net Insurance Benefits	$ 1,090,031	$ 616,547	$ 2,777,501	$ 1,772,698
General and Administrative Expenses	1,549,676	526,797	3,043,267	1,726,169
Income (Loss) from Operations	$ (459,645)	89,750	(265,766)	46,529
Other Income (Expense)
Interest Income		4,568	5,241	13,388
Interest Expense	$ (60,294)	$ (200,270)	$ (150,887)	(233,442)
Other, net				6,303
Total Other Expense	$ (60,294)	$ (195,702)	$ (145,646)	(213,751)
Loss Before Income Taxes	$ (519,939)	$ (105,952)	$ (411,412)	$ (167,222)
Income Tax Provision
Net Loss	$ (519,939)	$ (105,952)	$ (411,412)	$ (167,222)
Basic and Diluted:
Loss Per Share	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)
Weighted Average Number of Shares Outstanding	44,315,941	43,185,941	44,029,347	43,122,354

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Operating Activities
Net Loss	$ (411,412)	$ (167,222)
Adjustments to reconcile to cash from operating activities:
Share Based Compensation - Options	404,659	320,333
Accrued Interest on NIBs	(2,777,501)	(1,772,698)
Advance for Investments in Net Insurance Benefits	(626,914)	(794,598)
Refund of Advance for Investments in Net Insurance Benefits	854,920	904,274
Changes in Operating Assets and Liabilities
Accrued Interest Income	16,428	(4,847)
Prepaid Expenses	(1,875)	(1,750)
Accounts Payable	23,767	75,339
Accrued Expenses	927,672	34,430
Net Cash from Operating Activities	$ (1,590,256)	(1,406,739)
Investing Activity
Issuance of Note Receivable		(150,000)
Proceeds from Notes Receivable	$ 211,000	550,000
Net Cash from Investing Activity	211,000	400,000
Financing Activities
Proceeds from Issuance of Notes Payable and Lines-of-Credit, Related Party	1,167,000	$ 1,272,000
Proceeds from Issuance of Convertible Debenture	$ 700,000
Common Stock Issued for Cash		$ 150,000
Redemption of Temporary Equity	$ (750,000)
Net Cash from Financing Activities	1,117,000	$ 1,422,000
Net Change in Cash	(262,256)	415,261
Cash at Beginning of Period	336,370	375,212
Cash at End of Period	$ 74,114	790,473
Non Cash Financing & Investing Activities
Notes Receivables Exchanged for Advance for Investment in NIBs		100,000
Cash Paid for Interest		81,621
Adjustments to Subscription Receivable and Additional Paid in Capital		$ 1,500
Exchange Note Payable and Accrued Interest for Temporary Equity	$ 1,500,000
Advanced funds paid converted to Net Insurance Benefits	$ 3,368,380

XML 18 R6.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
ORGANIZATION AND BASIS OF PRESENTATION	Dec. 31, 2015
ORGANIZATION AND BASIS OF PRESENTATION [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	(1) ORGANIZATION AND BASIS OF PRESENTATION The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the March 31, 2015, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company's consolidated condensed financial statements and accompanying notes. Actual results could differ materially from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented. Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies,” the “Company” or “we”). The Company is engaged in the business of purchasing or acquiring and selling life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” Currently, the Company is focused on the purchase and sale of net insurance benefit contracts (“NIB”) on life insurance policies between the sellers and purchasers, but does not take possession or control of the policies. The purchasers acquire the life insurance policies at a discount to their face value for investment purposes. The purchasers have available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the NIB after all borrowings, interest and expenses have been paid out of the settlement proceeds.

XML 19 R7.htm IDEA: XBRL DOCUMENT

NEW ACCOUNTING PRONOUNCEMENTS	9 Months Ended
NEW ACCOUNTING PRONOUNCEMENTS	Dec. 31, 2015
NEW ACCOUNTING PRONOUNCEMENTS [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(2) NEW ACCOUNTING PRONOUNCEMENTS In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The Company is currently evaluating the guidance, including which transition approach will be applied and the estimated impact it will have on our consolidated financial statements. The Company does not believe adoption of this ASU will have a material impact on its financial statements. In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements. In April, 2015, the FASB issued ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs (Subtopic 835-30). This update requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. Under current standards, debt issuance costs are generally recorded as an asset and amortization of these deferred financing costs is recorded in interest expense. Under the new standard, debt issuance costs will continue to be amortized over the life of the debt instrument and amortization will continue to be recorded in interest expense. ASU 2015-03 is effective for the Company on April 1, 2016, and will be applied on a retrospective basis. In May 2015, the FASB issued ASU 2015-08, Business Combinations (Topic 805): Pushdown Accounting. This Accounting Standards Update amends various SEC paragraphs pursuant to the issuance of Staff Accounting Bulletin No.115. The Company notes the Update is effective immediately and will apply to the Company if the Company acquires a business. In August 2015, the FASB issued ASU 2015-15, Interest-Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. This Update was issued to make some fairly minor wording adjustments to ASC 835-30. The new wording, presented as paragraph 835-30-S45-1, recognizes that ASU 2015-13 does not address the presentation and subsequent measurement of debt issuance costs related to line-of-credit arrangements. As stated below, ASU 2015-13 requires companies to recognize debt issuance costs as a reduction of the carrying amount of the associated debt liability. ASU 2015-15 states that debt issuance costs related to line-of-credit arrangements may be recognized as an asset and amortized over the term of the line-of-credit arrangement, even if the line-of-credit does not carry a balance. The Company notes that this guidance does apply to its reporting requirements and will implement the new guidance accordingly. In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. This Update, which is part of the FASB's larger Simplification Initiative project aimed at reducing the cost and complexity of certain areas of the accounting codification, requires that an acquirer recognize adjustments to provisional amounts identified during the measurement period in the reporting period in which the adjustment amounts are determined. Furthermore, the acquirer should record in the same period's financial statements, the effect on earnings from any changes in depreciation, amortization or other items impacting income. These changes resulting from adjustments to provisional amounts should be calculated as if the accounting had been completed at the actual acquisition date. Lastly, the Update requires the acquirer to present separately on the face of the income statement or in the footnote disclosures the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the actual acquisition date. This Update is effective for fiscal years beginning after December 15, 2016. The amendments in this Update should be applied prospectively to adjustments to provisional amounts that occur after the effective date of this Update, with earlier application permitted. The amendments are effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. All entities have the option of adopting the new requirements as of an earlier date for financial statements that have not been previously issued. Applicable disclosures for a change in an accounting principle are required in the year of adoption, including interim periods. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. The Company notes that this guidance may apply to its reporting requirements and will implement the new guidance accordingly. In November 2015, the FASB issued ASU 2015-17 regarding Balance Sheet Classification of Deferred Taxes, which simplifies the presentation of deferred income taxes by requiring all deferred income tax liabilities and assets be classified as noncurrent on the consolidated balance sheets. The guidance is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2016, with early adoption permitted. The standard would be effective for the Company's fiscal year beginning April 1, 2017, however, we expect to early adopt the provisions of this standard effective January 1, 2016 on a prospective basis. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements. In January 2016, the FASB issued ASI 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company's fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company does not expect the early adoption of this guidance to have a material effect on our consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

XML 20 R8.htm IDEA: XBRL DOCUMENT

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	9 Months Ended
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	Dec. 31, 2015
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	(3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. According to the Del Mar ATA, Del Mar, with the assistance of Europa, was obligated to convert the NIBs and other newly acquired NIBs into “Qualified NIBS.” As soon as Del Mar met its obligation to provide Qualified NIBs to the Company, any remaining NIBs and any other consideration and collateral would be returned or released to Del Mar. The original due date for the conversion was December 31, 2013, which date was subsequently extended several times. On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related Europa Agreement to extend the deadline until August 31, 2015. The remaining consideration and collateral under the Del Mar ATA, as of September 1, 2015, primarily consisted of approximately 81% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. During June 2015, one of the life settlement policies matured for $10,000,000 (the “Matured Policy”), lowering the remaining face value of such life settlement policies to $84,000,000. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a senior lender. As Del Mar was unable to provide the required amount of Qualified NIBs by the extended due date of August 31, 2015, effective September 1, 2015, the agreements with Del Mar and Europa were cancelled and the Company obtained full ownership and control of the collateral, which included the above mentioned approximately 81% of the NIBs associated with the $84,000,000 face value of life settlement policies and certain rights to net proceeds relating to the Matured Policy. The bulk of the $10,000,000 proceeds paid in connection with the Matured Policy were used to repay loans secured by such Matured Policy. However, on September 10, 2015, the Company received $1,094,335 as a result of the rights associated with the Matured Policy. These proceeds were allocated $239,415 to pay off a note receivable (including interest), $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar and $307,612 as a refund of advance payments previously made to or on behalf of Del Mar as part of the Del Mar ATA. The $547,308 and $307,612 proceeds, which together total $854,920, were applied to reduce Advance for Investment in NIBs. On September 30, 2015, the Company transferred the remaining balance of advances and expense payments to Del Mar, totaling $3,368,380, which approximates fair value. This amount was residing in advance for investment in NIBs before being transferred to investment in NIBs (see Note 4). In addition to obtaining full and unrestricted rights to the NIBs upon termination of the Del Mar ATA and Europa Agreement, the Company also is entitled to receive liquidated damages from Del Mar in an amount equal to 100% of any cash advances made under the Del Mar ATA. The Company is currently determining the extent of the liquidated damages claim and Del Mar's ability to pay any such liquidated damages. The liquidated damages are computed pro rata, based upon the percentage of Qualified NIBs delivered by Del Mar under the Del Mar ATA. The Company received $90,600,000 in Qualified NIBs or approximately 22.65% of the $400,000,000 in Qualified NIBs due under the Del Mar ATA. Accordingly, once 22.65% of its costs and expenses are deducted, the Company would be entitled to receive the remaining amount of its costs and expenses, times two, as liquidated damages. As a result of the termination, the Company has no further payment obligations to Del Mar or fee obligations to Europa. The Company is determining whether Europa is liable to the Company for any damages related to Del Mar's failure to provide the required Qualified NIBs. The liquidated damages claim is secured by all of the assets transferred to the Company under the Del Mar ATA and a Collateral Pledge Agreement executed by Del Mar on June 5, 2013, pledging all of Del Mar's remaining assets to the Company unless and until Del Mar completes all of its obligations under the Del Mar ATA. The Company is unsure what, if any, assets are currently held by Del Mar.

XML 21 R9.htm IDEA: XBRL DOCUMENT

INVESTMENT IN NET INSURANCE BENEFITS

9 Months Ended

Dec. 31, 2015

INVESTMENT IN NET INSURANCE BENEFITS [Abstract]

INVESTMENT IN NET INSURANCE BENEFITS

(4) INVESTMENT IN NET INSURANCE BENEFITS

Investment in NIBs for the nine months ended December 31, 2015, and the fiscal year ended March 31, 2015, were as follows:

	December 31, 2015		March 31, 2015
Beginning Balance	$	22,544,635	$	12,243,411
Additional investments		3,368,380		7,846,746
Accretion of interest income		2,777,501		2,454,478
Distributions of investments		-		-
Impairment of investments		-		-
Total	$	28,690,516	$	22,544,635

As mentioned in Note 3, the Company transferred $3,368,380 from advance for investment in NIBs into investment in NIBs on September 30, 2015.

The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”). Future expected cash flow is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment and service provider or other third-party payments. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2015. The Company holds between 81% and 100% in the NIBs relating to the underlying life insurance policies as of December 31, 2015.

The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations. Subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income. We have not recognized any significant adverse change in future estimated cash flows relating to our investment in NIBs from January 31, 2013 (inception) to the period ended December 31, 2015.

During July, 2015, a group of persons located in the United States (the “Purchasers”) acquired the entities that owned all of the portfolios of life insurance contracts underlying the Company's NIBs. The Purchasers have also agreed to amend the NIBs agreements to provide greater disclosure to the Company and limit permitted expenses to be paid prior to payments to the NIBs holders, pending certain regulatory and tax approvals. In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a Settlement Agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts. The Purchasers further required releases from the Company and the payment of certain accrued expenses. Accordingly, effective as of July 17, 2015, the Purchasers acquired all of the ownership interests in the entities that owned all of the portfolios of life insurance contracts underlying the Company's NIBs from their prior owners and executed a Settlement Agreement with such owners and the Company in relation to these matters. The NIBs amendments are in process, and the Company believes the NIBs amendments will be in effect within the next three months. The Company and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership or management of the entities sold, based on actions that occurred prior to this sale to the Purchasers. During the three months ended December 31, 2015, the Company accrued for an $826,665 obligation related to the ownership change, which is recorded in General and Administrative Expenses. Management of the Company is presently not aware of the existence of any additional payments owed. Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in our NIBs ownership interest. The Company was supportive of the Purchasers acquiring the entities that owned the portfolios of life insurance contracts underlying the Company's NIBs and was willing to provide the indemnification because it believes this ownership change will result in a reduction of costs and expenses associated with ownership of the NIBs, which should increase their intrinsic value.

XML 22 R10.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY	9 Months Ended
NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY	Dec. 31, 2015
NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY [Abstract]
NOTES PAYBALE AND LINES-OF-CREDIT, RELATED PARTY	(5) NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY As of December 31, 2015, the Company had borrowed $2,667,000 from related parties under notes payable and lines-of-credit Agreements that allow for borrowings of up to $3,245,000 through the earlier of June 30, 2017, or when the Company completes a successful equity raise, at which time principal and interest is due in full. The notes payable and lines-of-credit incur interest at 7.5 percent, allow for origination fees and are collateralized by Advance for Investment in NIBs. The Company borrowed $1,367,000 under these agreements during the nine months ended December 31, 2015. The Company also repaid $200,000 during the nine months ended December 31, 2015. The related parties include a person who is the Chairman of the Board of Directors and a stockholder and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. See Note 10 for amendment of this agreement subsequent to period end.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

XML 23 R11.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	9 Months Ended
	Dec. 31, 2015
NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE [Abstract]
NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	(6) NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE At March 31, 2014, the Company owed $1,455,904, including accrued interest for notes payable. During the year ended March 31, 2015, the Company had accrued an additional $37,350 in interest. The note incurred interest at 4%, was collateralized by NIBs and was due April 2015. During the three months ended June 30, 2015, the note payable and related accrued interest was converted to temporary equity through the issuance of 187,500 shares of common stock with a redemption feature (See Part II, Item 5, below). On June 9, 2015, the holder of the redemption feature exercised a portion of the redemption right relating to 93,750 shares and, as a result, the holder accepted the Company's redemption payment of $750,000. The redemption feature on the remaining 93,750 shares was eligible to be exercised by the holders on October 31, 2015. The holders of the redemption feature exercised the redemption feature on October 31, 2015, thus requiring the Company to pay the redemption feature, and the Company originally had elected to exercise its 45 day Cure Period to make the redemption payment of $750,000 on or before December 15, 2015, in consideration of the cancellation of the 93,750 common shares. As a result of the redemption feature being exercised by the holder, the $750,000 associated with the redemption has been reclassified from Temporary Equity to Redeemed Common Stock Payable. To date the cure period with the holder of the redemption feature has expired. The Company and the redemption holder are negotiating the terms and conditions of an extension agreement and anticipate completion by February 15, 2016.

XML 24 R12.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBENTURE AGREEMENT	9 Months Ended
CONVERTIBLE DEBENTURE AGREEMENT	Dec. 31, 2015
CONVERTIBLE DEBENTURE AGREEMENT [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(7) CONVERTIBLE DEBENTURE AGREEMENT On June 2, 2015, the Company entered into an 8% Convertible Debenture Agreement that allows for borrowings of up to $3,000,000 through June 2, 2016, at which time principal and interest is due in full. On June 2, 2016, the holder can elect to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company. The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share. As of December 31, 2015, the Company owed $700,000 under the agreement. Management has concluded there is currently no beneficial conversion feature associated with this instrument, as the conversion date is a year after the agreement was initiated and is also contingent. See Note 10 for amendment of this agreement subsequent to period end.

XML 25 R13.htm IDEA: XBRL DOCUMENT

LIQUIDITY AND CAPITAL REQUIREMENTS	9 Months Ended
LIQUIDITY AND CAPITAL REQUIREMENTS	Dec. 31, 2015
LIQUIDITY AND CAPITAL REQUIREMENTS [Abstract]
LIQUIDITY AND CAPITAL REQUIREMENTS	(8) LIQUIDITY AND CAPITAL REQUIREMENTS Under the current business plan, the Company purchases life insurance policies and residual interests in or financial products tied to life insurance policies when they fit its model and its cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein the Company committed to purchase a certain number of Qualified NIBs as Del Mar made them available). The Company expects to finance NIB purchases, as well as its operating working capital requirements, with proceeds from planned public and/or private offerings of its securities and debt financing. There can be no assurance that the Company will be successful in the anticipated equity and debt offerings or that it will be successful in raising additional capital in the future on terms acceptable to the Company, or at all. If the Company is unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases. Under this plan, expenditures for NIBs will be curtailed. The Company believes that it will be able to fund its operating working capital requirements with existing lines-of-credit and debentures agreements. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. To continue as a going concern beyond the period ended December 31, 2016, and in order to continue to purchase NIBs, the Company will need to complete planned equity and debt offerings or obtain alternative sources of financing. Absent additional financing, the Company will not have the resources to execute its current business plan.

XML 26 R14.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS	9 Months Ended
STOCK OPTIONS	Dec. 31, 2015
STOCK OPTIONS [Abstract]
STOCK OPTIONS	(9) STOCK OPTIONS On July 22, 2015, the Board of Directors approved an amendment to modify the vesting schedule for stock options issued to an executive. The amendment clarified that the option to purchase 400,000 shares of the Company's $0.001 par value common stock at $5.00 per share, with a five year term, expiring March 31, 2018, was at a vesting rate of 11,111 stock options monthly, commencing with October, 2013, and ending with September 30, 2016, subject to continued employment with the Company. As a result of this modification, the Company recorded a true-up amortization expense of $98,655 during the three months ended September 30, 2015, to adjust the amortization of the stock options to the amended vesting schedule as of the modification date of July 22, 2015. In addition, the Company adjusted the going forward quarterly amortization, beginning with the three months ended September 30, 2015, of the stock options from $73,202 to $78,728. No incremental value was applied to the amended stock options and, therefore, the original grant date fair value continues to be applicable.

XML 27 R15.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2015
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	(10) SUBSEQUENT EVENTS On February 4, 2016, the Notes Payable and Lines-of-Credit Agreement – Related Party (See Note 5) was amended to allow for increased borrowings of $1,985,000. With the new increase in effect, the total borrowings allowed from the related party entities was increased from $3,245,000 to $5,230,000. All other terms of the Agreement remain in effect. The related parties include a person who is the Chairman of the Board of Directors and a stockholder and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. On February 2, 2016, the Convertible Debenture Agreement (See note 7) was amended to extend the due date from June 2, 2016 to May 31, 2017. All other terms of the Agreement remain in effect.

XML 28 R16.htm IDEA: XBRL DOCUMENT

INVESTMENT IN NET INSURANCE BENEFITS (Tables)

9 Months Ended

Dec. 31, 2015

INVESTMENT IN NET INSURANCE BENEFITS [Abstract]

Summary of Investments in Net Insurance Benefits

	December 31, 2015		March 31, 2015
Beginning Balance	$	22,544,635	$	12,243,411
Additional investments		3,368,380		7,846,746
Accretion of interest income		2,777,501		2,454,478
Distributions of investments		-		-
Impairment of investments		-		-
Total	$	28,690,516	$	22,544,635

XML 29 R17.htm IDEA: XBRL DOCUMENT

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)		1 Months Ended	9 Months Ended
	Sep. 10, 2015	Jun. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2015	Aug. 31, 2015	May. 31, 2015
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
Collateral as Percentage of NIBs			81.00%
Face Value Of Collateral Against Cash Advances					$ 3,368,380	$ 84,000,000	$ 94,000,000
Contracts that matured during the period		$ 10,000,000
Proceeds from matured policy	$ 1,094,335
Proceeds allocated to note receivable payoff	239,415
Proceeds allocated to reimbursement	547,308
Proceeds allocated to refund advance payments	$ 307,612
Proceeds allocated to reduce advance for Investments in NIBs			$ 854,920	$ 904,274
Advance for investments, cash advances, rate			100.00%
Net insurance benefits received			$ 90,600,000
Net insurance benefits, amount received, percentage			22.65%
Net insurance benefits, future amount			$ 400,000,000

XML 30 R18.htm IDEA: XBRL DOCUMENT

INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2015
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
Beginning Balance			$ 22,544,635	$ 12,243,411	$ 12,243,411
Additional investments			3,368,380		7,846,746
Accretion of interest income	$ 1,090,031	$ 616,547	$ 2,777,501	$ 1,772,698	$ 2,454,478
Distributions of investments
Impairment of investments
Total	$ 28,690,516		$ 28,690,516		$ 22,544,635
Transfers from Advance for Investment in NIBs			$ 3,368,380

XML 31 R19.htm IDEA: XBRL DOCUMENT

INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)	Dec. 31, 2015	Mar. 31, 2015
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs	100.00%
Accrued obligation related to ownership change	$ 826,665	$ 181,917
Minimum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs	81.00%
Maximum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs	100.00%

XML 32 R20.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (Details) - Stockholder [Member]	9 Months Ended
	Dec. 31, 2015 USD ($)
Related Party Transaction [Line Items]
Long-term Line of Credit	$ 2,667,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,245,000
Related party note interest rate	7.50%
Proceeds from Lines of Credit	$ 1,367,000
Repayments of Lines of Credit	$ 200,000

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

XML 33 R21.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details)		3 Months Ended	12 Months Ended
	Jun. 09, 2015 USD ($) shares	Jun. 30, 2015 item	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($)	Mar. 31, 2014 USD ($)
Debt Instrument [Line Items]
Number of shares repurchased during the period \| shares	93,750
Value of shares repurchased during the period	$ 750,000
Mandatorily Redeemable Common Stock liability				$ 750,000
NIB-Collateralized Note Payable [Member]
Debt Instrument [Line Items]
Notes Payable, including accrued interest					$ 1,455,904
Interest Payable			$ 37,350
Interest rate			4.00%
Maturity date			Apr. 01, 2015
Number of shares issued on conversion \| item		187,500

XML 34 R22.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBENTURE AGREEMENT (Details)	9 Months Ended
CONVERTIBLE DEBENTURE AGREEMENT (Details)	Dec. 31, 2015 USD ($) $ / shares
CONVERTIBLE DEBENTURE AGREEMENT [Abstract]
Convertible debenture interest rate	8.00%
Convertible debenture borrowing capacity	$ 3,000,000
Convertible debenture, terms of conversion	The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received
Convertible debenture, minimum conversion price per share \| $ / shares	$ 1.00
Convertible debenture, amount borrowed	$ 700,000

XML 35 R23.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS (Narrative) (Details) - USD ($)		3 Months Ended
STOCK OPTIONS (Narrative) (Details) - USD ($)	Jul. 22, 2015	Sep. 30, 2015	Dec. 31, 2015	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, par value per share			$ 0.001	$ 0.001
Option expense amortized		$ 98,655
Quarterly amortization expense going forward		78,728
Scenario, Previously Reported [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Quarterly amortization expense going forward		$ 73,202
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted	400,000
Common Stock, par value per share	$ 0.001
Exercise price	$ 5.00
Stock option term	5 years
Shares vesting per month	11,111

XML 36 R24.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details) - Stockholder [Member] - USD ($)	Feb. 04, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Maximum amount borrowed under line of credit		$ 3,245,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Increase in maximum borrowing capacity	$ 1,985,000
Maximum amount borrowed under line of credit	$ 5,230,000

EXCEL 37 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 30 130 1 false 7 0 false 5 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.sundancestrategies.com/role/sund-daei DOCUMENT AND ENTITY INFORMATION Cover 1 false false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.sundancestrategies.com/role/Statement-CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.sundancestrategies.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.sundancestrategies.com/role/Statement-CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.sundancestrategies.com/role/Statement-CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.sundancestrategies.com/role/sund-oabop1 ORGANIZATION AND BASIS OF PRESENTATION Notes 6 false false R7.htm 102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS Sheet http://www.sundancestrategies.com/role/sund-nap NEW ACCOUNTING PRONOUNCEMENTS Notes 7 false false R8.htm 103 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS Sheet http://www.sundancestrategies.com/role/sund-afiinib1 ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS Notes 8 false false R9.htm 104 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS Sheet http://www.sundancestrategies.com/role/sund-iinib INVESTMENT IN NET INSURANCE BENEFITS Notes 9 false false R10.htm 105 - Disclosure - NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY Notes http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLEANDLINES-OF-CREDITRELATEDPARTY NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY Notes 10 false false R11.htm 106 - Disclosure - NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE Notes http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLETRANSFERREDTOREDEEMEDCOMMONSTOCKPAYABLE NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE Notes 11 false false R12.htm 107 - Disclosure - CONVERTIBLE DEBENTURE AGREEMENT Sheet http://www.sundancestrategies.com/role/Disclosure-CONVERTIBLEDEBENTUREAGREEMENT CONVERTIBLE DEBENTURE AGREEMENT Notes 12 false false R13.htm 108 - Disclosure - LIQUIDITY AND CAPITAL REQUIREMENTS Sheet http://www.sundancestrategies.com/role/sund-lacr LIQUIDITY AND CAPITAL REQUIREMENTS Notes 13 false false R14.htm 109 - Disclosure - STOCK OPTIONS Sheet http://www.sundancestrategies.com/role/sund-so1 STOCK OPTIONS Notes 14 false false R15.htm 110 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.sundancestrategies.com/role/sund-se SUBSEQUENT EVENTS Notes 15 false false R16.htm 304 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Tables) Sheet http://www.sundancestrategies.com/role/sund-iinibt INVESTMENT IN NET INSURANCE BENEFITS (Tables) Tables http://www.sundancestrategies.com/role/sund-iinib 16 false false R17.htm 40301 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) Sheet http://www.sundancestrategies.com/role/sund-afiinibnd ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) Details http://www.sundancestrategies.com/role/sund-afiinib1 17 false false R18.htm 40401 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) Sheet http://www.sundancestrategies.com/role/sund-iinibsoiinibd INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) Details http://www.sundancestrategies.com/role/sund-iinibt 18 false false R19.htm 40403 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) Sheet http://www.sundancestrategies.com/role/sund-iinibnd INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) Details http://www.sundancestrategies.com/role/sund-iinibt 19 false false R20.htm 40501 - Disclosure - NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (Details) Notes http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLEANDLINES-OF-CREDITRELATEDPARTYDetails NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (Details) Details http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLEANDLINES-OF-CREDITRELATEDPARTY 20 false false R21.htm 40601 - Disclosure - NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details) Notes http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLETRANSFERREDTOREDEEMEDCOMMONSTOCKPAYABLEDetails NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details) Details http://www.sundancestrategies.com/role/Disclosure-NOTESPAYABLETRANSFERREDTOREDEEMEDCOMMONSTOCKPAYABLE 21 false false R22.htm 40701 - Disclosure - CONVERTIBLE DEBENTURE AGREEMENT (Details) Sheet http://www.sundancestrategies.com/role/Disclosure-CONVERTIBLEDEBENTUREAGREEMENTDetails CONVERTIBLE DEBENTURE AGREEMENT (Details) Details http://www.sundancestrategies.com/role/Disclosure-CONVERTIBLEDEBENTUREAGREEMENT 22 false false R23.htm 41201 - Disclosure - STOCK OPTIONS (Narrative) (Details) Sheet http://www.sundancestrategies.com/role/sund-sond1 STOCK OPTIONS (Narrative) (Details) Details http://www.sundancestrategies.com/role/sund-so1 23 false false R24.htm 41601 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.sundancestrategies.com/role/sund-sed SUBSEQUENT EVENTS (Details) Details http://www.sundancestrategies.com/role/sund-se 24 false false All Reports Book All Reports sund-20151231.xml sund-20151231.xsd sund-20151231_cal.xml sund-20151231_def.xml sund-20151231_lab.xml sund-20151231_pre.xml true true ZIP 43 0000912282-16-000555-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912282-16-000555-xbrl.zip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
R&$O!5ZUI$IVM-C4"HI1QL>1:E;>K^%^J9D?$&3L_:MK&^%'O.G=)6$ MQ;7MXZ$!OC"R7H?XAT%T'X3HH[O/9B;A>$"RS36>6,I$FN?08;7Q=4CD>4#D6>4A:!L=\+#GF+=_32=GFK280+R+.RA M_(.7YU#&ZE3^3L.P#Y4J>X%77C4Z<2M>5=+/O*OJ>B'^GE"P26I">:VV;.(W MWACBZ@16DXS7J=*UB]@SM+O=@C7M>\UHV4(4L:7?P.(+KQ-?1&I[F,GGM+@ MLWTP>)T7[S92CP9)C(4,;V$_#>MF6U;J**T]1M>(@K0B3,*O?&*0;+SR)D:PV1-)+U1U(0KB>Q]93_8QCE7HD M=-)H%3T-,H17Z>A9B5?$39*YB=C[@L%VE1\IX+*'$$(O;8B1@%A(0T:03*-< M 5ICD10/9J=WB::>)4DRK[#L_XF2K- ?IS7MW7AQ^0?8\B'#/QQ> GU"Q]G)L6?&? M\^8KL5'[M=96(VL+7.9;1LRWBMQYBXBL<,B1@_:.2F.TQATCU?=[7+K$4 I1 MO6 A@F1*6R(:.FV] 0=;2D6L= ;U.CQ4RE1['U$$/?3F1 "1FGN#(:ZLBC B MC>MU=D3#.D2C-FV4WN-V-8?H(D(JPHLRM@5D+[V,\VT_6T77$8)+I^X+KRN>45 FKJ M:8^Q.LFI2F-Y!5(=^NJ!9$7R7G]O6]6.Z$\]T1N2$UW=>K))!H5<27M C#2V MUT5PBFK @E]:9ML6BBAMO0*2B+P]L$09WNN#BYI,MV&Z E$4Q #F4MCB=*0# MC=K15]2):4(/!*FTO+ZJ5KO1(G:DS^] OW3$.=P?1E$: M6SK79?465"RUV^RZZ:.W] YB0Y'TQ1B/B]2IB MG\H11,>K_NEC_O0_8)4MX6T0KS'A]P>P!MM]O8LU %ML9K@R31@O8O ;"!(* M*#6/WH*PMM$] [P9K?8R#VTLC6P))+ST$5[R>(=6LWZ9X9#]/%0MCCV$%I., MEJ1S)L^7D7QI>^&(.+S7QTUUB6I/HV$U1$&:AIL0K,4!)C@" WC<$3P&I)QV MM &52U:U?*4CEVEK&A%.]1+J0__*\I.^[)TMX ISG6T(/VBK- C[+(([B$NV M+!CU[:,FOD5S L.2Q*LMIY]'&ZV7:+D(YK9O9T[1V_N'2U'A^T*00:'@V'[L6WEDN;95:R[%N$"3Z2J\IO8;A@HJZ8M*,9)>AQ'J M=>;BLL3]"XR00&GY+K'X:EJH.Z-,(+N[2W@5DY1YQ"5WZ4*4-OO@:R17>VJ" M\4')Q]UXH#4(EDQ]WU:072-)+HM$N@H0UH1&.+)H5$/V,WBS!=@>3('DOQ6HFTE_'JRA?HW_> MPZ1 1Y8EX5.>X7W,$N*O!T[(AU&$2W3L"YGS2D68)]BNHFJ0H->&--A,:#1$ MDSQ7ANQG@E6MS,XA2>8>IL4[0>*%8;E=Z05B&5VMFXF4A)TK>LKUCJBTNI?U MQEMS2DKABN= FJ9"G+JE7$S*(WF4]\ * 9;P')1EUEO6K]"S_E2=:$\'H"CR M4537!A5[K.^9%+DJ>N'IEIPBY@7<;F%<"$O+*!#NV,XB$.CH"2Z5=:$$2QEJ M7B>MU21AUE6A-.LD K2;>88NCIR]L-0=^W#$Z&?@X+YBF0L?1LMN+91N2\] MQ)>V%XZ(PWL=@3I>.K]":G]\0?.QU$BF6TV:"6*EJ_I%4RJQ$Q!=7C$H$" M.DVCM@#:>U3/P*Q7B[V WYL5Z7WQ2[$ /6?90\6>(].[=@^P1H)0:(;5K2M=I8=UTB\P/%1*2X#0:%NMVW1O9ZUTX4>?8EI'U] MN>U%3*1L[R:@&K) %>\@ RY,K7&\R*(R/J"ACPXH7L.105NGDPCD:IWT12KW M))8@V9+"D81?UV..C5^[:0Q=54.N;#+P/XQ_B"(VQK44E*',]GT2OJ*%SGT4 MK(HP_+%L*[%&KU2?.B[X?7P#BZ06^B&(3\R2'Z7 BBC678[7%H>?IK,\>X%) M^&^PKIV,D@#7?[0Z%/N,YAM(M6FN'WS[L&$M%$F!]E40)D5HZ\AYF052G'Y5 M?%_ [F&/:O*6Z^X96==WT@Z<47<\++I T,O\"DE68 O256=5TL/]M>B:S MD!4=2V1]RQ_+(X3KU)HRW'LR41WF>YKFQOP,/8)5GI27:(,HPJ_/MA4@8P;R MHXH8A,RH8S$-94V:,1(9=@Y+%S\S\ Z?Q1GZ I;%.E/\VM$J ^M?8(04&X79 M^P/:EU L0WZ =EE7B0$\Q+NR?GI#6X;R'L5_&QV&"4='M=PAQ9QEX%<2XNYB2R"CNL6I0>=?H3>F]1LGKMT(.9_;QNMSLXOIYEV&Z MBF":)X!SFUVR-SF%A]_;.C1EY>3AE.06*1@5),T%[)[D'JR?=1S\V4SA.VK@ MX]UB.7^\G_TV.[^9+Q]F=X]7\X>'^>5R@?XWG]_.+R\6M[>+N\?EXN*?^V:7 M.&<^2JVE_^%JO,=753I>JV5EG-8MJZ*VUA;P>Y3\X"!*$)A# M2"S%PFA&14;5S$],$(74@89J8*^#"TV):\\F5$'"\@Y-[2$\H:6:S$#,59S8 M0#X@4YNBY+';A[371WE-@6^##,>[WR_IH0E^!R9:FQW\125#<%WH:Y+P^IIV M4[!ZM*0H#;>F[@?4!V"BD#V OZB44(PNE+))>EV<:GHKV87+DQ+&,.A#R0*6 MHON59/F2N(X\[%@YB>:#J[-XS7TX2:)GRP*$>OJ$;GE5J"-7B);7P:T;&#_C M1*/ZFU 4#+*:MA^B(#;U"64"PJK#BCRXU[>#B]LC#V"7)ZN7( 7K2[1FCY_+ MDP]634+A?J3Z1.Q^/L%-5@WJV!.@I/SPI2.?69:(1?(1[6A*O*,$&JN.8X$C M41%F\%B1J@#YV4O7B)4@G"[";DS8S?.30:P=<+!2X1@MF4<6KB2_<>:)>C0A MD=9")D$_@FBGKTB[[\B1+#>6QJB*[?HS"<_426BCCJUZDD/4K37+9-0'HC=D MVJ4C%8&4H".>A2J%FD;>J?3NT#9@\!X%?3ZW6*8E(L: #*LI86/8;>H+; 0$ M50,.>6#5#:%MZ#2%O0NV@%FVC]>"A^P5 M$4*^.J>VJV6Z)G9CSK?-&;?$_&PQ/F\R;HE$@_6%L^>6],"H?G2[R%Y LO][ MRJS:*MBK!2QN+^<01B_J*J"W"Y[818*I[=K'E]UV M'D&*)Z4RB @#ZXOU62_N'89Q^!2OIPL^%J2]"E: >"E(M#E3WGISZW:LG,1% M%5I7RE:=@->?@],Z=7?\9'@ZZ)L.^D[EH.]8F3F=15&QSJ[_B!WIE.O@>M@Y*+);PM7Q*8/[^TY)$!N-A((NCFC30V M:$MISBRN>:Q8NOA( ?4#R/($6V'YL;E/X&N8XE*0BY@B( G0ZJ/4P:PRBJ] M[JTQ/2!684/_'4@OIJUW&JCXU(BDA4J7JK%]QB"XZL6'N:Q[)JK#M(^UI(?Q M&+(]=:8-S_)\>'V<_[AZ >L\ HM-32^L4WU^AW:\E]'!8[P*ZT$;,ED45:L^ M67>X4X+4E" UY:AXGZ/B'6(>@OB9G ',:-%"2:.%-4EN@R^X_!]3%F*;EC2M M-M;Q3M(_%!.) O#:B'54MT;R-;2^+P/)Q@&I31L'S3;.XX ADB0.FB-Y[=D8 M>16=WY.\FB,9%%U>H8B#9LU[>RG4&$7KG%O0E\"FI*U \6P3^N =??J=:4(4 M](:3,RK6261O?$/+('4>4%(ZZ(4R'J7A/^*4V,7B+09)^A+NCA7ZJCI/U_'= M]3DQ5"'I"!U$VGC+( -5\]VFRU2G+$:Q@\X?(VA]" MLG9:,X6MM;;N%>1*ZO E[E56ASC\B&Y_[39AEL)XG=F\ %:JRA$JJCX!!O^@P^T6JI M*IZ8^$-IL3%XQA7%;0>FR3+65E12&"7T$X)HH]^8$$I7B#F -FA6G[<1X'.6 MI@"O\.M:X:.3U8N.37(O[Y$IH S-N"13K/(&Y=.Y819$SF%2:GU#[<)#HW.K MF@-;$D)+".N6O=&GC65J*O;5H<0TK88]C<.<%CN =CAA_'R#5UI!DKQO8/(6 M)&N!Q8CH"#S\L4;P'Y;"^M&-5A9AKQ,\.Y+BK-42$U$$W_"^712\])X\T))Z M^@]6KCYT@Y1$4/J8R/%E-/I+];/]1=(+N,5_EH+'ZW,0 WR>5-1K/\>WF.H- M+F J_-772(IG %I(^6\Q^C6NV\2T<%A],+[V\WW*ZW@%MP!K0C0"(M"C4U.# MT<,ZT$7DX1ZQT'=2U"L!5*K\PY4&M3Q%5&#QOED080R&$+]J^>-7GWL\N.+8 MW3C5&>)M<[5-#H'0P3%(''NY&]9)X9F]>,YA%A:;N@-^ +B2\!K[X=)%/V$7 M?1^\BU0)TC-H>RW04\3(VXCBG;)%L7Y+9ZLL?$6+MR('EN==]0U, MS516'WB$/E:[OHV[61TS>'T91CGBEN-^)7NWC%^XMS6'RN%032MJVG# MS\G.-E15"<5;"=*ONR4NW:HDE9]1&*)X,JB4P>(($3@L[M2_<(X\2MR62LX- MRKF_4;J]H=U=V\UY^QSVKR!\?L%"(WZ"9W"7XXNU^[5FNLBS- OB-9*P3]6DN +!7BU7P.WE$QSE5* .0RX=2T\"Z5SOX1LB M5V@B<&WP,,Z1U1W#@^=@ Q-PR!4$Z6T8%ZF7524AI)GF*/,_<_3KLJ@X_W:S M!0Z(Z]*!./#)Q.Q-C;JY#LJS\DM)+MP%/&A@[\GVUP!X^?#DUK1<^'9K_^#/ M$[DO5 GC6WIZ41>LJ@)S6+K#)40JK)BM.["BM/8+5B(B]X$597RO+WW>@>SH ME"E@(K9I0:C5QB?@L,13ATMKU#U(_N;E)^T.QK#">RG4WK5R3E:$^[7!Q._G M%< DU= #='Q*EA[LTP/$15,XAL]BM&R!C=C2)WCQ154'%'%LKTMU_!2$<8KE M .DBGG_!LN5A^H(5L-C@$HNTHR'1?NW#(7X_ZV 3=U!072$4$')I-PZ-^#2] M7HU5:TSV*26E%651[\XII!+,V,+J %6'@K1_H!&(^7U63=5![*[ MG=@*^0$U6 #LPQ:'E]REH\@RF+/+%.[?T! MIY.?&)12A0X@\@CJVY=:OY.-BYC']@J8.U:49\C\G\T&X(NHQRC4 YJA!["" M\2J,PM(HLRNPQI%GO._-$2/OC<:T'"%]([?SB'2,;-T'21;9T:_.?K5XM/"C M?"SBPB*.7M42>>BP#/%>TNU#MCOM#([;W3>D*RJF'YS%B7J]\9 NLBM=4]?I M$KK:D#@0]CP_F_LY3M#WX#D._UW4;*NJ.Q[4<@_B(,+U]8H\%Y%S/ TCMO#: M:T3? *U/??T0WXL/K\-Q*I+O7[+3:!*M$368Q&'$4S )LOJ&-XD#'\KG4FZ> M!&3308#%JFFX8!6,<5HI?F23F!@H62Y->41JG32%$7US3/K4U\\Q]>+#Z^7K M47*1PPY)FU ?DFH4*D/Z:Q6]%:C++%08\?K@ZRAZIR W6IS4RJ9+FH32:%1K MD!S-7T/HHS9=-B#)PXB>WPW#.'RRN6 ]7 *:15$1,:S_B+=VE>E,S6IA=U9P M4X5BL\&51G# MK4C-,=2A*:I7$6$%.Q@E%BRM-6E@/?C&JSQ#_G.>9N$6Y[HAY6S#?)N6=82+ M.WZ%*O8+:1QO0,L)Y$KA.;@/PO4BOHZ1 \9.:+_(E@&\-2X:1F.!"V\-S_:, M:3)>"V*,9%%-<7=';9?7?\77U:H#4I?6\@-Z:(W:]=C;L'1P-+:5=PJ+/VRF MCIW. OP2EQP)GW(\H33PT!V=O=[N@C I M[T8)U(MAMVZ;*ZVUA_"4TX"V#Q^5G&K\TYE2EZ=9J$(9=OWJ5DC#CE/&0GK# MX0CL!%>/148:DG>VA7E,6\GT&JL%6<6Q/ :T#NUI@[LB,ZJE@I YA7 ]CZU? M K5N#K^?30:A57^.F(3TB71I$H]9D&2VC>+P%"B #FR9EDF09PBMI>0#T1FVQ8"*6T]AIZ(]-HP1R&F7,++ M[=/&U73AUXM2G'J=2BNHD*M@!7X)HAR8LDD) FJV*$1@_#8HK^>A;4^(0Z_O^JHZ M(LQ^!W2,/73LRN],N@X_OG>=%?5;%+5>+Z/EBQ5S!/--L@G8 F MJR01F.RTWYQX9;DD:;Q.!="CB.4;-&K*M?&-6'(Q_F3(O6;$8SLNA#G)17#+ MGX6OM(HD^@F8^207!"9+[CVO)L@\0P;,Y$&IHMND5C,NK> M,^.E7;<$\OJI+DW+%<22V>]T@X*9%7=)83+JGK/BI4DWQ/'Z.EM_3=R!+]GR M#42OX!;]\D7WL32?D';S[A*:K%S/''EJ[%VI3BK(JRF4JRE@ZX\UR@17>X1N MM=J8 ,]]@KBG$3@ZB&M@1RLV=D\;\WP'.Y#AF=^Q&K;&$]ZA=G2@>R$K04"3 ML?J\116#%)WWL2@]G@R>1(T?Z1_^ZDK+X(Y\&21P&0'\0PNDO,@ M_F/Q%@-N"57Y 0C>4'0 ZTZOWZ5 )3UIO?0GRL&(2J#&PZ M0;[]/H$Q^NL*E#,4KR]>@O@9H(]"O4T8K\)=!'A>2>/(+7O4,K(U?W8)TE42 M[LI2G Q1[F#V&\AF:[C+J*\&]AJKI57%L:P[/)TX@WI52W&,&CBN>TU%3D?D M0&'P!'=GUGSH(GD.XO#?A71H(9W"*%R7%A"OZQ!8;*["& D2ED^I Y&UG=:Q MVX\\ZQG;WC/8??@_OHG$6S^:(J-S-HADK+MFO>"%@TT)Q6]K$:?Q9+AV,?0% M>*T[]62WLU>@ZP%$Q3,G09*]+W%5-#1S2,Q+N W"F.(GA/JTC)[31U_1?PJA M10QN UI_?Q[I7$ILGJ*8$BNM@TCR4Z>?32EJZN::(LHIQNMC4 M?B:G$]8(8NHAC^"JS78Q '7H2,Z(#TS4UXM2Q+W.]:-)^B64-.AZ#T&P%CU< M!6=#'CXNB8M/.21BB@(@K"@=8><:>'A'+:+=Q&#DP@') ]CMJX@O-G4V+\$3 M70G\+AT%L+JX:DC,\P4)+<@9$_$8@$W-\^=ICL\O?,)2 M<6"]EQRT5U V3V*/A\P?[Q;+^>/][+?9^QA^=LER((P2J?#V^GPULUSMNGP=CJ\G0YOW3WF.;W#6\S#8G.! M)B^DOXW1;=))5*TW<=6LF.>K#"DU'* V1UH5F"TN<R\Q*2J_!@ R2*G>R+.--HKX#^B'@^Q94;9 MPTO,B>O 7)"S).9UL80I0C]%Z$<4H3\&K42^V]SVC*CB&+[;HO)K 2&5E&KQ M-D>_VU,^B$?Y(*- 7"NR(P] Q@""B26D 9Q0DW" 13BJ0@ZEN&-]K,FD&*,& M"R10I1EDRPJ_&W##1@D[/&9P]<<+C! _]#@#M5$]L$!HY!1.*.$#GFP"6&@% M"0@C5G64O=N@7X8)6*&QB=A@-VK?9VXUYV&323$:@2Z<@ *N+4^8DF@@GH04-^6YL:EX';F]@ M$!?'PVF*1+JBERBCM6L'D[KMO 083UX-J"*0\+HD>SW*()BD+M*%$08:29*Z MA!8TP(Y-S>M7KJ9K$N.Y)B'],:1 MRQ5G>C+01CAE[EW)F.9)+:@Q\+01&=*2[^G=;1S7KN&SZ^ )"E]\6, MOX L7 61-8=TX+A63^\>IF$!;+93DNG:WD$)=;7FG"[@=@OC(H3X^(*F*;U. MTYQ:<)C3NB4ZM;5U!R,UGU!6?MIB1X!HW:E0B2GO&YPX;NN(-3WIJ*3W M' ,Z!?6B'Z5TPA5:_L]%E#,#D:<*4WVQ0 MK*#H9[3LOF)9Q7?*=>[$<,4Z>PM4)>UH@JPH;=4XFX/8%=CO\#LP,3J278^P M%HQ@D;CW^7XT^./N?L0Z">!P%'L@*6T8Q"-A)^1K_E57./[J4K"7 "K'L<:4 MTX=!7))6FC_X?=)G\SSS,WN]@!K@GQB*=.F?%[$[VTI.( MC(D'L*3["RG&S>"5X,S#_MJANA$6 XU4(W'"XPA:E:X$V',E^5,*_LR1\;274YO8<1XLEKJ/@M>>([)0CX,T>E)>;9O(44@UCIY,8D7&_V7L' M\M<@28+R$<^'\/FE>'&SYDPYMB[9NV4'PKWUW>3ED*19NE+?^KU?\;[6/8#L MG,)^ZJ$X!T$N#O>)Q:F/R6]DD^/0[3AT7XT@+UGQ M?'10NM78WVEIX&@(1[;_#?[?4Y""__S_4$L! A0#% @ M'-)2)++0PR\ M5P R+P" !$ ( ! '-U;F0M,C Q-3$R,S$N>&UL4$L! M A0#% @ M'-)2 /72]'^% 3AD! !$ ( !ZU< '-U M;F0M,C Q-3$R,S$N>'-D4$L! A0#% @ M'-)2$?Z4"8H% (Y0! !4 M ( !&&T '-U;F0M,C Q-3$R,S%?8V%L+GAM;%!+ 0(4 Q0 M ( +1S24BJ5W+[01L #:U 0 5 " 7.! !S=6YD+3(P M,34Q,C,Q7V1E9BYX;6Q02P$"% ,4 " "T&UL4$L! A0#% M @ M'-)2)O>VF!*4@ ?K\& !4 ( !"W@! '-U;F0M,C Q C-3$R,S%?<')E+GAM;%!+!08 !@ & (H! "(R@$ ! end